{"query": "what drugs may treat conditions related to Ehlers-Danlos syndrome, hypermobility type?", "results": [{"name": "cyclosporine", "paths": ["cyclosporine-[causes increased activity of]-COL3A1-[gene associated with condition]-Ehlers-Danlos syndrome, hypermobility type", "cyclosporine-[treats or applied or studied to treat]-gingival overgrowth-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "cyclosporine-[treats or applied or studied to treat]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "cyclosporine-[treats or applied or studied to treat]-xerophthalmia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "citalopram", "paths": ["citalopram-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "citalopram-[treats]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "citalopram-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "citalopram-[applied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "citalopram-[applied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "citalopram-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "lidocaine", "paths": ["lidocaine-[preventative for condition]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "lidocaine-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "lidocaine-[in clinical trials for]-scoliosis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "lidocaine-[in clinical trials for]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "lidocaine-[preventative for condition]-Myalgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "lidocaine-[treats or applied or studied to treat]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "lidocaine-[in clinical trials for]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "lidocaine-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "lidocaine-[in clinical trials for]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "lidocaine-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "lidocaine-[in clinical trials for]-severe cutaneous adverse reaction-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "lidocaine-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "lidocaine-[in clinical trials for]-Myalgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "lidocaine-[in clinical trials for]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "lidocaine-[preventative for condition]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "sodium chloride", "paths": ["sodium chloride-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "sodium chloride-[in clinical trials for]-constipation disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "sodium chloride-[in clinical trials for]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "sodium chloride-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "sodium chloride-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "sodium chloride-[in clinical trials for]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "sodium chloride-[in clinical trials for]-Raynaud disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "sodium chloride-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "sodium chloride-[in clinical trials for]-scoliosis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "sodium chloride-[in clinical trials for]-Striae distensae-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "sodium chloride-[in clinical trials for]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "sodium chloride-[in clinical trials for]-severe cutaneous adverse reaction-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "Adrenal Cortex Hormones", "paths": ["Adrenal Cortex Hormones-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Adrenal Cortex Hormones-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Adrenal Cortex Hormones-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Adrenal Cortex Hormones-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Adrenal Cortex Hormones-[treats or applied or studied to treat]-central nervous system origin vertigo-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Adrenal Cortex Hormones-[preventative for condition]-Nausea and vomiting-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Adrenal Cortex Hormones-[treats or applied or studied to treat]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Adrenal Cortex Hormones-[treats or applied or studied to treat]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Adrenal Cortex Hormones-[treats or applied or studied to treat]-severe cutaneous adverse reaction-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Adrenal Cortex Hormones-[treats or applied or studied to treat]-Myalgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "dexamethasone", "paths": ["dexamethasone-[in clinical trials for]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "dexamethasone-[in clinical trials for]-pelvic organ prolapse-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "dexamethasone-[in clinical trials for]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "dexamethasone-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "dexamethasone-[in clinical trials for]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "dexamethasone-[treats or applied or studied to treat]-Nausea and vomiting-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "dexamethasone-[in clinical trials for]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "dexamethasone-[preventative for condition]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "dexamethasone-[treats or applied or studied to treat]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "dexamethasone-[preventative for condition]-Nausea and vomiting-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "dexamethasone-[treats or applied or studied to treat]-central nervous system origin vertigo-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "dexamethasone-[in clinical trials for]-Nausea and vomiting-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "dexamethasone-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "dexamethasone-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "paracetamol", "paths": ["paracetamol-[treats]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "paracetamol-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "paracetamol-[in clinical trials for]-scoliosis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "paracetamol-[in clinical trials for]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "paracetamol-[treats or applied or studied to treat]-Myalgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "paracetamol-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "paracetamol-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "paracetamol-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "paracetamol-[in clinical trials for]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "paracetamol-[in clinical trials for]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "paracetamol-[in clinical trials for]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "paracetamol-[treats or applied or studied to treat]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "paracetamol-[applied to treat]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "paracetamol-[treats]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "melatonin", "paths": ["melatonin-[in clinical trials for]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "melatonin-[preventative for condition]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "melatonin-[preventative for condition]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "melatonin-[applied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "melatonin-[in clinical trials for]-gastroesophageal reflux disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "melatonin-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "melatonin-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "melatonin-[treats or applied or studied to treat]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "melatonin-[in clinical trials for]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "melatonin-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "melatonin-[preventative for condition]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "melatonin-[treats or applied or studied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "melatonin-[treats or applied or studied to treat]-gastroesophageal reflux disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "melatonin-[treats or applied or studied to treat]-Sleep abnormality-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "melatonin-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "melatonin-[preventative for condition]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "melatonin-[preventative for condition]-scoliosis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "melatonin-[applied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "melatonin-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "ONABOTULINUMTOXINA", "paths": ["ONABOTULINUMTOXINA-[in clinical trials for]-scoliosis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ONABOTULINUMTOXINA-[in clinical trials for]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ONABOTULINUMTOXINA-[in clinical trials for]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ONABOTULINUMTOXINA-[in clinical trials for]-severe cutaneous adverse reaction-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ONABOTULINUMTOXINA-[in clinical trials for]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ONABOTULINUMTOXINA-[in clinical trials for]-Raynaud disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ONABOTULINUMTOXINA-[in clinical trials for]-gingival overgrowth-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ONABOTULINUMTOXINA-[in clinical trials for]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ONABOTULINUMTOXINA-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "propranolol", "paths": ["propranolol-[preventative for condition]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "propranolol-[in clinical trials for]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "propranolol-[treats or applied or studied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "propranolol-[treats or applied or studied to treat]-Epistaxis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "propranolol-[applied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "propranolol-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "propranolol-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "propranolol-[applied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "propranolol-[applied to treat]-mitral valve prolapse-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "propranolol-[preventative for condition]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "propranolol-[treats or applied or studied to treat]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "propranolol-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "aspirin", "paths": ["aspirin-[in clinical trials for]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "aspirin-[in clinical trials for]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "aspirin-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "aspirin-[preventative for condition]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "aspirin-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "aspirin-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "aspirin-[in clinical trials for]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "aspirin-[treats or applied or studied to treat]-Raynaud disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "aspirin-[in clinical trials for]-Myalgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "aspirin-[treats]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "aspirin-[treats]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "aspirin-[preventative for condition]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "aspirin-[applied to treat]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "aspirin-[treats]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "aspirin-[treats or applied or studied to treat]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "pregabalin", "paths": ["pregabalin-[in clinical trials for]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "pregabalin-[in clinical trials for]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "pregabalin-[applied to treat]-Paresthesia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "pregabalin-[applied to treat]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "pregabalin-[applied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "pregabalin-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "pregabalin-[applied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "pregabalin-[applied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "pregabalin-[applied to treat]-Myalgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "pregabalin-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "pregabalin-[applied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "pregabalin-[in clinical trials for]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "fentanyl", "paths": ["fentanyl-[in clinical trials for]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "fentanyl-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "fentanyl-[applied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "fentanyl-[treats or applied or studied to treat]-constipation disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "fentanyl-[in clinical trials for]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "fentanyl-[in clinical trials for]-scoliosis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "fentanyl-[in clinical trials for]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "fentanyl-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "fentanyl-[applied to treat]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "bupivacaine", "paths": ["bupivacaine-[in clinical trials for]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "bupivacaine-[in clinical trials for]-ptosis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "bupivacaine-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "bupivacaine-[in clinical trials for]-Inguinal hernia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "bupivacaine-[in clinical trials for]-Umbilical hernia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "bupivacaine-[in clinical trials for]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "bupivacaine-[in clinical trials for]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "colecalciferol", "paths": ["colecalciferol-[preventative for condition]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "colecalciferol-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "colecalciferol-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "colecalciferol-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "colecalciferol-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "colecalciferol-[in clinical trials for]-gingivitis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "colecalciferol-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "colecalciferol-[treats or applied or studied to treat]-Myalgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "fluoxetine", "paths": ["fluoxetine-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "fluoxetine-[applied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "fluoxetine-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "fluoxetine-[treats or applied or studied to treat]-Raynaud disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "fluoxetine-[treats]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "fluoxetine-[applied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "fluoxetine-[in clinical trials for]-gastroesophageal reflux disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "fluoxetine-[treats or applied or studied to treat]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "fluoxetine-[preventative for condition]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "fluoxetine-[treats or applied or studied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "fluoxetine-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "duloxetine", "paths": ["duloxetine-[treats or applied or studied to treat]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "duloxetine-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "duloxetine-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "duloxetine-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "duloxetine-[in clinical trials for]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "duloxetine-[applied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "duloxetine-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "duloxetine-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "duloxetine-[applied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "duloxetine-[in clinical trials for]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "duloxetine-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "duloxetine-[in clinical trials for]-Myalgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "duloxetine-[applied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "Botulinum Toxins", "paths": ["Botulinum Toxins-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Botulinum Toxins-[treats or applied or studied to treat]-Myalgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Botulinum Toxins-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Botulinum Toxins-[treats or applied or studied to treat]-severe cutaneous adverse reaction-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Botulinum Toxins-[treats or applied or studied to treat]-Raynaud disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Botulinum Toxins-[treats or applied or studied to treat]-constipation disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Botulinum Toxins-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Botulinum Toxins-[preventative for condition]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "ibuprofen", "paths": ["ibuprofen-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ibuprofen-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ibuprofen-[in clinical trials for]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ibuprofen-[treats]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ibuprofen-[preventative for condition]-Myalgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ibuprofen-[in clinical trials for]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ibuprofen-[in clinical trials for]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ibuprofen-[applied to treat]-Myalgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ibuprofen-[applied to treat]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ibuprofen-[applied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ibuprofen-[treats or applied or studied to treat]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ibuprofen-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ibuprofen-[applied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ibuprofen-[in clinical trials for]-Myalgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ibuprofen-[in clinical trials for]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "cortisol", "paths": ["cortisol-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "cortisol-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "cortisol-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "cortisol-[affects]-TGFB1-[physically interacts with]-COL5A1-[gene associated with condition]-Ehlers-Danlos syndrome, hypermobility type", "cortisol-[treats or applied or studied to treat]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "cortisol-[preventative for condition]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "cortisol-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "cortisol-[in clinical trials for]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "cortisol-[treats or applied or studied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "cortisol-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "gabapentin", "paths": ["gabapentin-[in clinical trials for]-scoliosis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "gabapentin-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "gabapentin-[treats or applied or studied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "gabapentin-[in clinical trials for]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "gabapentin-[preventative for condition]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "gabapentin-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "gabapentin-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "gabapentin-[in clinical trials for]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "gabapentin-[applied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "gabapentin-[applied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "gabapentin-[in clinical trials for]-pelvic organ prolapse-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "gabapentin-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "gabapentin-[applied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "diclofenac", "paths": ["diclofenac-[in clinical trials for]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "diclofenac-[applied to treat]-Myalgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "diclofenac-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "diclofenac-[applied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "diclofenac-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "diclofenac-[treats or applied or studied to treat]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "diclofenac-[applied to treat]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "diclofenac-[treats]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "diclofenac-[in clinical trials for]-Myalgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "diclofenac-[in clinical trials for]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "diclofenac-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "diclofenac-[in clinical trials for]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "diclofenac-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "diclofenac-[in clinical trials for]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "caffeine", "paths": ["caffeine-[treats or applied or studied to treat]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "caffeine-[treats or applied or studied to treat]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "caffeine-[in clinical trials for]-Apnea-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "caffeine-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "caffeine-[applied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "caffeine-[applied to treat]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "caffeine-[treats]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "caffeine-[in clinical trials for]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "caffeine-[treats or applied or studied to treat]-Apnea-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "caffeine-[treats]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "caffeine-[in clinical trials for]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "caffeine-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "caffeine-[preventative for condition]-Apnea-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "caffeine-[preventative for condition]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "caffeine-[applied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "naloxone", "paths": ["naloxone-[in clinical trials for]-constipation disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "naloxone-[preventative for condition]-constipation disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "naloxone-[treats or applied or studied to treat]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "naloxone-[treats or applied or studied to treat]-Apnea-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "naloxone-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "naloxone-[in clinical trials for]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "naloxone-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "naloxone-[treats or applied or studied to treat]-constipation disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "naloxone-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "naloxone-[in clinical trials for]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "magnesium sulfate", "paths": ["magnesium sulfate-[in clinical trials for]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "magnesium sulfate-[treats]-constipation disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "magnesium sulfate-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "magnesium sulfate-[treats or applied or studied to treat]-constipation disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "magnesium sulfate-[in clinical trials for]-constipation disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "magnesium sulfate-[treats or applied or studied to treat]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "magnesium sulfate-[preventative for condition]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "magnesium sulfate-[in clinical trials for]-scoliosis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "Fish Oils", "paths": ["Fish Oils-[applied to treat]-gingivitis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Fish Oils-[applied to treat]-Raynaud disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Fish Oils-[applied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Fish Oils-[preventative for condition]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Fish Oils-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Fish Oils-[applied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Fish Oils-[applied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "Opioids", "paths": ["Opioids-[treats or applied or studied to treat]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Opioids-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Opioids-[treats or applied or studied to treat]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Opioids-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Opioids-[treats or applied or studied to treat]-constipation disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Opioids-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Opioids-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Opioids-[preventative for condition]-constipation disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "venlafaxine", "paths": ["venlafaxine-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "venlafaxine-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "venlafaxine-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "venlafaxine-[applied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "venlafaxine-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "venlafaxine-[treats or applied or studied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "venlafaxine-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "venlafaxine-[applied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "simvastatin", "paths": ["simvastatin-[in clinical trials for]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "simvastatin-[treats or applied or studied to treat]-Myalgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "simvastatin-[preventative for condition]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "simvastatin-[in clinical trials for]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "ketorolac", "paths": ["ketorolac-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ketorolac-[in clinical trials for]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ketorolac-[in clinical trials for]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ketorolac-[in clinical trials for]-scoliosis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ketorolac-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "midazolam", "paths": ["midazolam-[in clinical trials for]-Inguinal hernia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "midazolam-[preventative for condition]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "midazolam-[treats]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "midazolam-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "midazolam-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "midazolam-[in clinical trials for]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "midazolam-[treats or applied or studied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "Anti-Inflammatory Agents, Non-Steroidal", "paths": ["Anti-Inflammatory Agents, Non-Steroidal-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Anti-Inflammatory Agents, Non-Steroidal-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Anti-Inflammatory Agents, Non-Steroidal-[preventative for condition]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Anti-Inflammatory Agents, Non-Steroidal-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Anti-Inflammatory Agents, Non-Steroidal-[treats or applied or studied to treat]-gastroesophageal reflux disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Anti-Inflammatory Agents, Non-Steroidal-[treats or applied or studied to treat]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Anti-Inflammatory Agents, Non-Steroidal-[treats or applied or studied to treat]-Myalgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Anti-Inflammatory Agents, Non-Steroidal-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "analgesic", "paths": ["analgesic-[treats or applied or studied to treat]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "analgesic-[treats or applied or studied to treat]-constipation disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "analgesic-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "analgesic-[preventative for condition]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "analgesic-[treats or applied or studied to treat]-Myalgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "analgesic-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "analgesic-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "analgesic-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "propofol", "paths": ["propofol-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "propofol-[treats or applied or studied to treat]-Hypotonia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "propofol-[in clinical trials for]-scoliosis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "propofol-[in clinical trials for]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "propofol-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "ondansetron", "paths": ["ondansetron-[preventative for condition]-Nausea and vomiting-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ondansetron-[treats or applied or studied to treat]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ondansetron-[treats or applied or studied to treat]-central nervous system origin vertigo-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ondansetron-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ondansetron-[treats or applied or studied to treat]-Nausea and vomiting-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ondansetron-[in clinical trials for]-Nausea and vomiting-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "celecoxib", "paths": ["celecoxib-[applied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "celecoxib-[applied to treat]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "celecoxib-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "celecoxib-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "celecoxib-[treats or applied or studied to treat]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "celecoxib-[in clinical trials for]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "celecoxib-[treats]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "celecoxib-[in clinical trials for]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "celecoxib-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "celecoxib-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "celecoxib-[in clinical trials for]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "celecoxib-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "nifedipine", "paths": ["nifedipine-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "nifedipine-[applied to treat]-Raynaud disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "nifedipine-[treats or applied or studied to treat]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "nifedipine-[preventative for condition]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "nifedipine-[in clinical trials for]-Raynaud disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "nifedipine-[treats or applied or studied to treat]-gingival overgrowth-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "nifedipine-[treats or applied or studied to treat]-Raynaud disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "cyclobenzaprine", "paths": ["cyclobenzaprine-[in clinical trials for]-Myalgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "cyclobenzaprine-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "cyclobenzaprine-[in clinical trials for]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "cyclobenzaprine-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "methylprednisolone", "paths": ["methylprednisolone-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "methylprednisolone-[treats or applied or studied to treat]-central nervous system origin vertigo-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "methylprednisolone-[in clinical trials for]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "methylprednisolone-[in clinical trials for]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "methylprednisolone-[in clinical trials for]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "methylprednisolone-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "methotrexate", "paths": ["methotrexate-[treats or applied or studied to treat]-severe cutaneous adverse reaction-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "methotrexate-[in clinical trials for]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "methotrexate-[treats or applied or studied to treat]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "methotrexate-[treats or applied or studied to treat]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "methotrexate-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "clonidine", "paths": ["clonidine-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "clonidine-[in clinical trials for]-scoliosis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "clonidine-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "clonidine-[in clinical trials for]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "clonidine-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "clonidine-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "indomethacin", "paths": ["indomethacin-[in clinical trials for]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "indomethacin-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "indomethacin-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "indomethacin-[in clinical trials for]-Myalgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "indomethacin-[treats]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "indomethacin-[in clinical trials for]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "methadone", "paths": ["methadone-[in clinical trials for]-Nausea and vomiting-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "methadone-[in clinical trials for]-scoliosis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "methadone-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "methadone-[in clinical trials for]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "methadone-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "methadone-[treats or applied or studied to treat]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "buprenorphine", "paths": ["buprenorphine-[treats]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "buprenorphine-[applied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "buprenorphine-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "buprenorphine-[applied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "buprenorphine-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "buprenorphine-[applied to treat]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "buprenorphine-[in clinical trials for]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "risperidone", "paths": ["risperidone-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "risperidone-[applied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "risperidone-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "risperidone-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "risperidone-[applied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "risperidone-[treats or applied or studied to treat]-Sleep abnormality-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "testosterone propionate", "paths": ["testosterone propionate-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "testosterone propionate-[treats or applied or studied to treat]-Decreased fertility-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "testosterone propionate-[applied to treat]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "testosterone propionate-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "morphine", "paths": ["morphine-[treats or applied or studied to treat]-constipation disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "morphine-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "morphine-[in clinical trials for]-scoliosis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "morphine-[treats]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "morphine-[in clinical trials for]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "morphine-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "morphine-[in clinical trials for]-constipation disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "morphine-[preventative for condition]-constipation disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "morphine-[treats or applied or studied to treat]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "haloperidol", "paths": ["haloperidol-[applied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "haloperidol-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "haloperidol-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "haloperidol-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "haloperidol-[applied to treat]-Nausea and vomiting-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "haloperidol-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "Basis", "paths": ["Basis-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Basis-[treats or applied or studied to treat]-constipation disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Basis-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Basis-[preventative for condition]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Basis-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Basis-[treats or applied or studied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Basis-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "cannabidiol", "paths": ["cannabidiol-[in clinical trials for]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "cannabidiol-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "cannabidiol-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "cannabidiol-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "cannabidiol-[in clinical trials for]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "cannabidiol-[treats or applied or studied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "cannabidiol-[preventative for condition]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "cannabidiol-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "cannabidiol-[in clinical trials for]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "Calcium Channel Blockers", "paths": ["Calcium Channel Blockers-[treats or applied or studied to treat]-central nervous system origin vertigo-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Calcium Channel Blockers-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Calcium Channel Blockers-[treats or applied or studied to treat]-Raynaud disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Calcium Channel Blockers-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Calcium Channel Blockers-[treats or applied or studied to treat]-gingival overgrowth-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Calcium Channel Blockers-[treats or applied or studied to treat]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Calcium Channel Blockers-[preventative for condition]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Calcium Channel Blockers-[preventative for condition]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "pregabalin", "paths": ["pregabalin-[treats or applied or studied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "pregabalin-[treats or applied or studied to treat]-Sleep abnormality-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "pregabalin-[preventative for condition]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "pregabalin-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "pregabalin-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "pregabalin-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "pregabalin-[treats or applied or studied to treat]-central nervous system origin vertigo-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "Metric (substance)", "paths": ["Metric (substance)-[treats or applied or studied to treat]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Metric (substance)-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Metric (substance)-[treats or applied or studied to treat]-keratoconus-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Metric (substance)-[treats or applied or studied to treat]-gastroesophageal reflux disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Metric (substance)-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "immunological adjuvant", "paths": ["immunological adjuvant-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "immunological adjuvant-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "immunological adjuvant-[treats or applied or studied to treat]-severe cutaneous adverse reaction-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "immunological adjuvant-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "immunological adjuvant-[treats or applied or studied to treat]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "capsaicin", "paths": ["capsaicin-[in clinical trials for]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "capsaicin-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "capsaicin-[in clinical trials for]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "capsaicin-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "capsaicin-[in clinical trials for]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "capsaicin-[in clinical trials for]-Myalgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "capsaicin-[applied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "codeine", "paths": ["codeine-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "codeine-[in clinical trials for]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "codeine-[in clinical trials for]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "codeine-[in clinical trials for]-constipation disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "naproxen", "paths": ["naproxen-[in clinical trials for]-Myalgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "naproxen-[treats]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "naproxen-[treats or applied or studied to treat]-Myalgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "naproxen-[treats or applied or studied to treat]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "naproxen-[treats]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "naproxen-[applied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "naproxen-[treats]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "naproxen-[applied to treat]-Myalgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "naproxen-[in clinical trials for]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "naproxen-[applied to treat]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "naproxen-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "naproxen-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "naproxen-[treats]-Myalgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "naproxen-[in clinical trials for]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "naproxen-[applied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "naproxen-[in clinical trials for]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "olanzapine", "paths": ["olanzapine-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "olanzapine-[applied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "olanzapine-[preventative for condition]-Nausea and vomiting-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "olanzapine-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "olanzapine-[applied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "olanzapine-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "olanzapine-[treats or applied or studied to treat]-Nausea and vomiting-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "olanzapine-[applied to treat]-Nausea and vomiting-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "olanzapine-[applied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "5-hydroxytryptamine", "paths": ["5-hydroxytryptamine-[preventative for condition]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "5-hydroxytryptamine-[treats or applied or studied to treat]-constipation disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "5-hydroxytryptamine-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "5-hydroxytryptamine-[treats or applied or studied to treat]-Nausea and vomiting-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "5-hydroxytryptamine-[treats or applied or studied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "lacosamide", "paths": ["lacosamide-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "lacosamide-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "lacosamide-[in clinical trials for]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "lacosamide-[in clinical trials for]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "ubidecarenone", "paths": ["ubidecarenone-[treats or applied or studied to treat]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ubidecarenone-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ubidecarenone-[preventative for condition]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ubidecarenone-[treats or applied or studied to treat]-Myalgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ubidecarenone-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "prazosin", "paths": ["prazosin-[treats or applied or studied to treat]-Sleep abnormality-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "prazosin-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "prazosin-[treats or applied or studied to treat]-Raynaud disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "prazosin-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "promethazine", "paths": ["promethazine-[in clinical trials for]-central nervous system origin vertigo-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "promethazine-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "promethazine-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "promethazine-[treats]-Nausea and vomiting-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "promethazine-[treats or applied or studied to treat]-Nausea and vomiting-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "quetiapine", "paths": ["quetiapine-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "quetiapine-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "quetiapine-[treats or applied or studied to treat]-Sleep abnormality-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "quetiapine-[applied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "quetiapine-[applied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "quetiapine-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "esomeprazole", "paths": ["esomeprazole-[in clinical trials for]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "esomeprazole-[treats or applied or studied to treat]-gastroesophageal reflux disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "esomeprazole-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "esomeprazole-[in clinical trials for]-gastroesophageal reflux disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "esomeprazole-[applied to treat]-gastroesophageal reflux disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "esomeprazole-[treats]-gastroesophageal reflux disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "esomeprazole-[in clinical trials for]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "oxygen", "paths": ["oxygen-[part of]-PROPRANOLOL HYDROCHLORIDE-[has part]-propranolol-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "oxygen-[part of]-intervertebral disk of third cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "oxygen-[treats or applied or studied to treat]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "oxygen-[part of]-intervertebral disk of seventh cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "oxygen-[preventative for condition]-Apnea-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "oxygen-[part of]-intervertebral disk of cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "oxygen-[part of]-intervertebral disk of thoracic vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "oxygen-[part of]-DEXPROPRANOLOL HYDROCHLORIDE-[has part]-propranolol-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "oxygen-[treats or applied or studied to treat]-Apnea-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "oxygen-[part of]-intervertebral disk of lumbar vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "oxygen-[part of]-intervertebral disk of sixth cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "oxygen-[part of]-Anaerocult(TM)-[has part]-silicon dioxide-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "oxygen-[part of]-tail intervertebral disc-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "oxygen-[part of]-proteoglycan-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "oxygen-[part of]-intervertebral disk of fifth cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "oxygen-[part of]-intervertebral disk of axis-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "oxygen-[part of]-schreckstoff-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "oxygen-[part of]-intervertebral disk of sacral vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "oxygen-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "oxygen-[part of]-intervertebral disk of atlas-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "oxygen-[in clinical trials for]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "oxygen-[part of]-intervertebral disk of fourth cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "oxygen-[part of]-nucleus pulposus-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "oxygen-[part of]-hydrated silica-[has part]-silicon dioxide-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "oxygen-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "atenolol", "paths": ["atenolol-[applied to treat]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "atenolol-[applied to treat]-mitral valve prolapse-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "atenolol-[treats or applied or studied to treat]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "atenolol-[preventative for condition]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "metformin", "paths": ["metformin-[in clinical trials for]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "metformin-[in clinical trials for]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "metformin-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "metformin-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "memantine", "paths": ["memantine-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "memantine-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "memantine-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "memantine-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "memantine-[in clinical trials for]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "memantine-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "amlodipine", "paths": ["amlodipine-[in clinical trials for]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "amlodipine-[in clinical trials for]-Raynaud disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "amlodipine-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "L-ascorbic acid", "paths": ["L-ascorbic acid-[applied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "L-ascorbic acid-[treats or applied or studied to treat]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "L-ascorbic acid-[applied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "L-ascorbic acid-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "L-ascorbic acid-[preventative for condition]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "L-ascorbic acid-[in clinical trials for]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "L-ascorbic acid-[in clinical trials for]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "oxytocin", "paths": ["oxytocin-[in clinical trials for]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "oxytocin-[in clinical trials for]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "oxytocin-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "(-)-adrenaline", "paths": ["(-)-adrenaline-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "(-)-adrenaline-[in clinical trials for]-Epistaxis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "(-)-adrenaline-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "(-)-adrenaline-[in clinical trials for]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "(-)-adrenaline-[treats or applied or studied to treat]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "amitriptyline", "paths": ["amitriptyline-[applied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "amitriptyline-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "amitriptyline-[preventative for condition]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "amitriptyline-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "amitriptyline-[treats]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "amitriptyline-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "amitriptyline-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "amitriptyline-[in clinical trials for]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "amitriptyline-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "Adrenergic beta-Antagonists", "paths": ["Adrenergic beta-Antagonists-[preventative for condition]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Adrenergic beta-Antagonists-[treats or applied or studied to treat]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Adrenergic beta-Antagonists-[preventative for condition]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Adrenergic beta-Antagonists-[treats or applied or studied to treat]-mitral valve prolapse-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Adrenergic beta-Antagonists-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Adrenergic beta-Antagonists-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "atorvastatin", "paths": ["atorvastatin-[treats or applied or studied to treat]-Myalgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "atorvastatin-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "atorvastatin-[preventative for condition]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "paroxetine", "paths": ["paroxetine-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "paroxetine-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "paroxetine-[treats]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "paroxetine-[preventative for condition]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "paroxetine-[applied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "paroxetine-[applied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "paroxetine-[treats or applied or studied to treat]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "paroxetine-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "tramadol", "paths": ["tramadol-[treats]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "tramadol-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "tramadol-[in clinical trials for]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "tramadol-[applied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "tramadol-[applied to treat]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "tramadol-[treats]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "tramadol-[in clinical trials for]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "tramadol-[in clinical trials for]-central nervous system origin vertigo-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "tramadol-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "L-carnitine", "paths": ["L-carnitine-[treats or applied or studied to treat]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "L-carnitine-[in clinical trials for]-Muscle weakness-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "L-carnitine-[applied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "L-carnitine-[applied to treat]-xerophthalmia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "botulinum toxin type A", "paths": ["botulinum toxin type A-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "botulinum toxin type A-[treats or applied or studied to treat]-Raynaud disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "botulinum toxin type A-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "botulinum toxin type A-[preventative for condition]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "botulinum toxin type A-[treats or applied or studied to treat]-severe cutaneous adverse reaction-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "ergocalciferol", "paths": ["ergocalciferol-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ergocalciferol-[treats or applied or studied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ergocalciferol-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ergocalciferol-[applied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ergocalciferol-[in clinical trials for]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "sirolimus", "paths": ["sirolimus-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "sirolimus-[treats or applied or studied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "sirolimus-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "lorazepam", "paths": ["lorazepam-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "lorazepam-[treats or applied or studied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "lorazepam-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "lorazepam-[applied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "lorazepam-[treats]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "lorazepam-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "lorazepam-[in clinical trials for]-central nervous system origin vertigo-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "lorazepam-[applied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "WATER", "paths": ["WATER-[treats or applied or studied to treat]-constipation disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "WATER-[preventative for condition]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "WATER-[in clinical trials for]-gingivitis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "WATER-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "WATER-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "ropivacaine", "paths": ["ropivacaine-[in clinical trials for]-Inguinal hernia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ropivacaine-[in clinical trials for]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ropivacaine-[in clinical trials for]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "TONICS", "paths": ["TONICS-[treats or applied or studied to treat]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "TONICS-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "tranexamic acid", "paths": ["tranexamic acid-[in clinical trials for]-Epistaxis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "tranexamic acid-[in clinical trials for]-scoliosis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "tranexamic acid-[treats or applied or studied to treat]-Epistaxis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "tranexamic acid-[applied to treat]-Epistaxis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "tranexamic acid-[in clinical trials for]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "tranexamic acid-[in clinical trials for]-pelvic organ prolapse-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "metoclopramide", "paths": ["metoclopramide-[applied to treat]-gastroesophageal reflux disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "metoclopramide-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "metoclopramide-[treats]-gastroesophageal reflux disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "metoclopramide-[treats or applied or studied to treat]-Nausea and vomiting-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "metoclopramide-[in clinical trials for]-gastroesophageal reflux disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "metoclopramide-[treats or applied or studied to treat]-gastroesophageal reflux disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "metoclopramide-[in clinical trials for]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "naltrexone", "paths": ["naltrexone-[in clinical trials for]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "naltrexone-[in clinical trials for]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "naltrexone-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "naltrexone-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "naltrexone-[treats]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "naltrexone-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "naltrexone-[in clinical trials for]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "naltrexone-[in clinical trials for]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "Serotonin Uptake Inhibitors", "paths": ["Serotonin Uptake Inhibitors-[treats or applied or studied to treat]-central nervous system origin vertigo-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Serotonin Uptake Inhibitors-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Serotonin Uptake Inhibitors-[preventative for condition]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Serotonin Uptake Inhibitors-[treats or applied or studied to treat]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Serotonin Uptake Inhibitors-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Serotonin Uptake Inhibitors-[preventative for condition]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Serotonin Uptake Inhibitors-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "ketamine", "paths": ["ketamine-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ketamine-[preventative for condition]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ketamine-[in clinical trials for]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ketamine-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ketamine-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ketamine-[in clinical trials for]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ketamine-[preventative for condition]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ketamine-[treats or applied or studied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ketamine-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ketamine-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "trazodone", "paths": ["trazodone-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "trazodone-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "trazodone-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "trazodone-[applied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "trazodone-[treats or applied or studied to treat]-Sleep abnormality-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "Vitamin E", "paths": ["Vitamin E-[applied to treat]-Striae distensae-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Vitamin E-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Vitamin E-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Vitamin E-[applied to treat]-severe cutaneous adverse reaction-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Vitamin E-[applied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "BENZODIAZEPINE", "paths": ["BENZODIAZEPINE-[treats or applied or studied to treat]-Sleep abnormality-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "BENZODIAZEPINE-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "BENZODIAZEPINE-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "BENZODIAZEPINE-[treats or applied or studied to treat]-central nervous system origin vertigo-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "BENZODIAZEPINE-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "BENZODIAZEPINE-[treats or applied or studied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "imipramine", "paths": ["imipramine-[treats]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "imipramine-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "imipramine-[in clinical trials for]-gastroesophageal reflux disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "imipramine-[treats or applied or studied to treat]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "imipramine-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "imipramine-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "imipramine-[applied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "imipramine-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "quinine", "paths": ["quinine-[preventative for condition]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "quinine-[in clinical trials for]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "quinine-[in clinical trials for]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "quinine-[in clinical trials for]-constipation disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "quinine-[treats or applied or studied to treat]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "quinine-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "quinine-[in clinical trials for]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "ethanol", "paths": ["ethanol-[preventative for condition]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ethanol-[preventative for condition]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ethanol-[treats or applied or studied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ethanol-[treats or applied or studied to treat]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ethanol-[in clinical trials for]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ethanol-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ethanol-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ethanol-[in clinical trials for]-constipation disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "Marihuana", "paths": ["Marihuana-[treats or applied or studied to treat]-Nausea and vomiting-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Marihuana-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Marihuana-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Marihuana-[treats or applied or studied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Marihuana-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "dexmedetomidine", "paths": ["dexmedetomidine-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "dexmedetomidine-[preventative for condition]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "dexmedetomidine-[preventative for condition]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "dexmedetomidine-[in clinical trials for]-Inguinal hernia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "dexmedetomidine-[in clinical trials for]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "dexmedetomidine-[treats or applied or studied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "dexmedetomidine-[in clinical trials for]-scoliosis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "diltiazem", "paths": ["diltiazem-[treats or applied or studied to treat]-Raynaud disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "diltiazem-[in clinical trials for]-constipation disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "diltiazem-[treats or applied or studied to treat]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "colchicine", "paths": ["colchicine-[treats or applied or studied to treat]-constipation disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "colchicine-[in clinical trials for]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "colchicine-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "dopamine", "paths": ["dopamine-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "dopamine-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "dopamine-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "dopamine-[treats or applied or studied to treat]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "diphenhydramine", "paths": ["diphenhydramine-[applied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "diphenhydramine-[in clinical trials for]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "diphenhydramine-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "diphenhydramine-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "diphenhydramine-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "valproic acid", "paths": ["valproic acid-[preventative for condition]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "valproic acid-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "valproic acid-[in clinical trials for]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "valproic acid-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "valproic acid-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "valproic acid-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "triamcinolone", "paths": ["triamcinolone-[treats or applied or studied to treat]-severe cutaneous adverse reaction-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "triamcinolone-[in clinical trials for]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "triamcinolone-[affects]-TGFB1-[physically interacts with]-COL5A1-[gene associated with condition]-Ehlers-Danlos syndrome, hypermobility type", "triamcinolone-[applied to treat]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "triamcinolone-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "bupropion", "paths": ["bupropion-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "bupropion-[applied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "bupropion-[treats or applied or studied to treat]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "bupropion-[treats]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "bupropion-[applied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "bupropion-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "bupropion-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "prednisone", "paths": ["prednisone-[treats or applied or studied to treat]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "prednisone-[in clinical trials for]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "lansoprazole", "paths": ["lansoprazole-[treats]-gastroesophageal reflux disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "lansoprazole-[applied to treat]-gastroesophageal reflux disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "lansoprazole-[treats or applied or studied to treat]-gastroesophageal reflux disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "lansoprazole-[in clinical trials for]-gastroesophageal reflux disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "lansoprazole-[in clinical trials for]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "methylphenidate", "paths": ["methylphenidate-[in clinical trials for]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "methylphenidate-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "methylphenidate-[treats or applied or studied to treat]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "methylphenidate-[applied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "methylphenidate-[in clinical trials for]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "methylphenidate-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "metoprolol", "paths": ["metoprolol-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "metoprolol-[applied to treat]-mitral valve prolapse-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "metoprolol-[applied to treat]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "metoprolol-[in clinical trials for]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "metoprolol-[treats or applied or studied to treat]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "metoprolol-[preventative for condition]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "metoprolol-[preventative for condition]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "riboflavin", "paths": ["riboflavin-[treats or applied or studied to treat]-keratoconus-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "riboflavin-[preventative for condition]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "riboflavin-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "riboflavin-[applied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "riboflavin-[in clinical trials for]-keratoconus-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "riboflavin-[in clinical trials for]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "lamotrigine", "paths": ["lamotrigine-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "lamotrigine-[preventative for condition]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "lamotrigine-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "lamotrigine-[preventative for condition]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "lamotrigine-[applied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "lamotrigine-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "lamotrigine-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "lamotrigine-[applied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "PROPRANOLOL HYDROCHLORIDE", "paths": ["PROPRANOLOL HYDROCHLORIDE-[applied to treat]-mitral valve prolapse-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "PROPRANOLOL HYDROCHLORIDE-[in clinical trials for]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "PROPRANOLOL HYDROCHLORIDE-[in clinical trials for]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "tretinoin", "paths": ["tretinoin-[treats or applied or studied to treat]-Striae distensae-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "tretinoin-[in clinical trials for]-Striae distensae-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "tretinoin-[treats or applied or studied to treat]-xerophthalmia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "timolol", "paths": ["timolol-[preventative for condition]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "timolol-[in clinical trials for]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "timolol-[applied to treat]-mitral valve prolapse-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "mitomycin C", "paths": ["mitomycin C-[in clinical trials for]-keratoconus-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "mitomycin C-[treats or applied or studied to treat]-High myopia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "clomipramine", "paths": ["clomipramine-[applied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "clomipramine-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "clomipramine-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "clomipramine-[applied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "clomipramine-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "clomipramine-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "hydroxychloroquine", "paths": ["hydroxychloroquine-[in clinical trials for]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "hydroxychloroquine-[treats or applied or studied to treat]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "hydroxychloroquine-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "hydroxychloroquine-[treats or applied or studied to treat]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "mirtazapine", "paths": ["mirtazapine-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "mirtazapine-[applied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "mirtazapine-[treats or applied or studied to treat]-Sleep abnormality-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "mirtazapine-[applied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "mirtazapine-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "mirtazapine-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "alprazolam", "paths": ["alprazolam-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "alprazolam-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "alprazolam-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "alprazolam-[treats or applied or studied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "alprazolam-[in clinical trials for]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "alprazolam-[applied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "alprazolam-[treats]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "alprazolam-[applied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "dehydroepiandrosterone", "paths": ["dehydroepiandrosterone-[treats or applied or studied to treat]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "dehydroepiandrosterone-[applied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "dehydroepiandrosterone-[in clinical trials for]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "dehydroepiandrosterone-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "dehydroepiandrosterone-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "BUPRENORPHINE", "paths": ["BUPRENORPHINE-[in clinical trials for]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "BUPRENORPHINE-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "BUPRENORPHINE-[in clinical trials for]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "sertraline", "paths": ["sertraline-[treats or applied or studied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "sertraline-[preventative for condition]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "sertraline-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "sertraline-[applied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "sertraline-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "sertraline-[applied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "sertraline-[treats]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "sertraline-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "progesterone", "paths": ["progesterone-[treats or applied or studied to treat]-Decreased fertility-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "progesterone-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "progesterone-[preventative for condition]-Apnea-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "hydrocodone", "paths": ["hydrocodone-[in clinical trials for]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "hydrocodone-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "hydrocodone-[in clinical trials for]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "buspirone", "paths": ["buspirone-[in clinical trials for]-Apnea-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "buspirone-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "buspirone-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "buspirone-[applied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "buspirone-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "desvenlafaxine", "paths": ["desvenlafaxine-[applied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "desvenlafaxine-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "desvenlafaxine-[applied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "desvenlafaxine-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "folic acid", "paths": ["folic acid-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "folic acid-[applied to treat]-gingivitis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "folic acid-[applied to treat]-gingival overgrowth-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "folic acid-[in clinical trials for]-gingival overgrowth-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "folic acid-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "folic acid-[applied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "meloxicam", "paths": ["meloxicam-[applied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "meloxicam-[treats]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "meloxicam-[in clinical trials for]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "meloxicam-[applied to treat]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "meloxicam-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "meloxicam-[in clinical trials for]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "verapamil", "paths": ["verapamil-[treats or applied or studied to treat]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "verapamil-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "verapamil-[preventative for condition]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "verapamil-[in clinical trials for]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "verapamil-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "nortriptyline", "paths": ["nortriptyline-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "nortriptyline-[treats]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "nortriptyline-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "nortriptyline-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "nortriptyline-[in clinical trials for]-gastroesophageal reflux disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "prochlorperazine", "paths": ["prochlorperazine-[treats]-Nausea and vomiting-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "prochlorperazine-[applied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "prochlorperazine-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "prochlorperazine-[treats or applied or studied to treat]-Nausea and vomiting-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "prochlorperazine-[in clinical trials for]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "prochlorperazine-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "dextromethorphan", "paths": ["dextromethorphan-[in clinical trials for]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "dextromethorphan-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "oxymetazoline", "paths": ["oxymetazoline-[in clinical trials for]-ptosis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "oxymetazoline-[treats or applied or studied to treat]-Epistaxis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "topiramate", "paths": ["topiramate-[applied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "topiramate-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "topiramate-[preventative for condition]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "topiramate-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "topiramate-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "topiramate-[in clinical trials for]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "citric acid", "paths": ["citric acid-[treats]-gastroesophageal reflux disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "citric acid-[treats or applied or studied to treat]-gastroesophageal reflux disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "citric acid-[in clinical trials for]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "citric acid-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "temazepam", "paths": ["temazepam-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "temazepam-[treats or applied or studied to treat]-Sleep abnormality-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "temazepam-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "misoprostol (methyl ester)", "paths": ["misoprostol (methyl ester)-[in clinical trials for]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "misoprostol (methyl ester)-[in clinical trials for]-gastroesophageal reflux disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "misoprostol (methyl ester)-[applied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "acetylcysteine", "paths": ["acetylcysteine-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "acetylcysteine-[in clinical trials for]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "acetylcysteine-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "acetylcysteine-[treats or applied or studied to treat]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "acetylcysteine-[treats or applied or studied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "Oils, Volatile", "paths": ["Oils, Volatile-[preventative for condition]-gingivitis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Oils, Volatile-[treats or applied or studied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Oils, Volatile-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Oils, Volatile-[treats or applied or studied to treat]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "oxycodone", "paths": ["oxycodone-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "oxycodone-[in clinical trials for]-constipation disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "oxycodone-[in clinical trials for]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "oxycodone-[applied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "oxycodone-[preventative for condition]-constipation disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "oxycodone-[in clinical trials for]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "oxycodone-[treats or applied or studied to treat]-constipation disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "oxycodone-[in clinical trials for]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "oxycodone-[applied to treat]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "oxycodone-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "Vitamin supplementation", "paths": ["Vitamin supplementation-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Vitamin supplementation-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Vitamin supplementation-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Vitamin supplementation-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "acide gras essentiel", "paths": ["acide gras essentiel-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "acide gras essentiel-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "acide gras essentiel-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "acide gras essentiel-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "cyclooxygenase 2 inhibitor", "paths": ["cyclooxygenase 2 inhibitor-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "cyclooxygenase 2 inhibitor-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "cyclooxygenase 2 inhibitor-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "cyclooxygenase 2 inhibitor-[treats or applied or studied to treat]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "Antipsychotic Agents", "paths": ["Antipsychotic Agents-[treats or applied or studied to treat]-Sleep abnormality-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Antipsychotic Agents-[treats or applied or studied to treat]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Antipsychotic Agents-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Antipsychotic Agents-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "Hypnotics", "paths": ["Hypnotics-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Hypnotics-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Hypnotics-[treats or applied or studied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Hypnotics-[treats or applied or studied to treat]-Sleep abnormality-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "\u03949-tetrahydrocannabinol", "paths": ["\u03949-tetrahydrocannabinol-[treats or applied or studied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "\u03949-tetrahydrocannabinol-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "\u03949-tetrahydrocannabinol-[treats or applied or studied to treat]-Nausea and vomiting-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "\u03949-tetrahydrocannabinol-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "\u03949-tetrahydrocannabinol-[in clinical trials for]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "cannabinol", "paths": ["cannabinol-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "cannabinol-[in clinical trials for]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "cannabinol-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "cannabinol-[in clinical trials for]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "Tricyclic Antidepressive Agents", "paths": ["Tricyclic Antidepressive Agents-[treats or applied or studied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Tricyclic Antidepressive Agents-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Tricyclic Antidepressive Agents-[preventative for condition]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Tricyclic Antidepressive Agents-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Tricyclic Antidepressive Agents-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "Olives - dietary", "paths": ["Olives - dietary-[applied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Olives - dietary-[applied to treat]-Striae distensae-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Olives - dietary-[applied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "pramipexole", "paths": ["pramipexole-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "pramipexole-[in clinical trials for]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "pramipexole-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "nitroglycerin", "paths": ["nitroglycerin-[treats or applied or studied to treat]-Raynaud disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "nitroglycerin-[in clinical trials for]-Raynaud disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "nitroglycerin-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "digoxin", "paths": ["digoxin-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "digoxin-[treats or applied or studied to treat]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "digoxin-[preventative for condition]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "hyaluronan", "paths": ["hyaluronan-[treats or applied or studied to treat]-severe cutaneous adverse reaction-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "hyaluronan-[treats or applied or studied to treat]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "hyaluronan-[applied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "hyaluronan-[preventative for condition]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "hyaluronan-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "hyaluronan-[treats or applied or studied to treat]-gingivitis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "hyaluronan-[in clinical trials for]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "ketoprofen", "paths": ["ketoprofen-[in clinical trials for]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ketoprofen-[treats]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ketoprofen-[in clinical trials for]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ketoprofen-[in clinical trials for]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ketoprofen-[in clinical trials for]-Myalgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ketoprofen-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "omega-3 fatty acid", "paths": ["omega-3 fatty acid-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "omega-3 fatty acid-[treats or applied or studied to treat]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "omega-3 fatty acid-[preventative for condition]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "omega-3 fatty acid-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "omega-3 fatty acid-[preventative for condition]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "omega-3 fatty acid-[applied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "omega-3 fatty acid-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "estrogen", "paths": ["estrogen-[preventative for condition]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "estrogen-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "estrogen-[treats or applied or studied to treat]-Epistaxis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "estrogen-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "curcumin", "paths": ["curcumin-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "curcumin-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "curcumin-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "curcumin-[preventative for condition]-Myalgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "curcumin-[preventative for condition]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "phenytoin", "paths": ["phenytoin-[treats or applied or studied to treat]-gingival overgrowth-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "phenytoin-[preventative for condition]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "phenytoin-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "phenytoin-[treats or applied or studied to treat]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "phenytoin-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "rocuronium", "paths": ["rocuronium-[in clinical trials for]-Myalgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "rocuronium-[preventative for condition]-Myalgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "rocuronium-[treats or applied or studied to treat]-Hypotonia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "succinylcholine", "paths": ["succinylcholine-[treats or applied or studied to treat]-Hypotonia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "succinylcholine-[in clinical trials for]-Myalgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "nicardipine", "paths": ["nicardipine-[treats or applied or studied to treat]-Raynaud disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "nicardipine-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "nicardipine-[applied to treat]-Raynaud disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "potassium chloride", "paths": ["potassium chloride-[treats or applied or studied to treat]-constipation disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "potassium chloride-[in clinical trials for]-constipation disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "potassium chloride-[in clinical trials for]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "potassium chloride-[treats]-constipation disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "thioridazine", "paths": ["thioridazine-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "thioridazine-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "thioridazine-[regulates]-TMEM43-[gene associated with condition]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "magnesium hydroxide", "paths": ["magnesium hydroxide-[applied to treat]-constipation disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "magnesium hydroxide-[in clinical trials for]-gastroesophageal reflux disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "magnesium hydroxide-[treats or applied or studied to treat]-gastroesophageal reflux disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "magnesium hydroxide-[in clinical trials for]-constipation disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "magnesium hydroxide-[treats]-gastroesophageal reflux disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "magnesium hydroxide-[treats]-constipation disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "magnesium hydroxide-[treats or applied or studied to treat]-constipation disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "aripiprazole", "paths": ["aripiprazole-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "aripiprazole-[applied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "aripiprazole-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "aripiprazole-[applied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "aripiprazole-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "thioctic acid", "paths": ["thioctic acid-[has part]-hydrogen(.)-[part of]-propranolol-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "thioctic acid-[has part]-water-[part of]-propranolol-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "thioctic acid-[has part]-water-[part of]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "thioctic acid-[in clinical trials for]-severe cutaneous adverse reaction-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "thioctic acid-[has part]-SULFUR, PRECIPITATED-[part of]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "thioctic acid-[has part]-hydrogen(.)-[part of]-silicon dioxide-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "thioctic acid-[applied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "thioctic acid-[has part]-SULFUR, PRECIPITATED-[part of]-METHANESULFONYLMETHANE-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "thioctic acid-[has part]-water-[part of]-silicon dioxide-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "salbutamol", "paths": ["salbutamol-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "salbutamol-[treats or applied or studied to treat]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "nadolol", "paths": ["nadolol-[treats or applied or studied to treat]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "nadolol-[applied to treat]-mitral valve prolapse-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "dexamfetamine", "paths": ["dexamfetamine-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "dexamfetamine-[treats or applied or studied to treat]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "immunoglobulins, intravenous", "paths": ["immunoglobulins, intravenous-[treats or applied or studied to treat]-dysautonomia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "immunoglobulins, intravenous-[treats or applied or studied to treat]-Muscle weakness-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "diazepam", "paths": ["diazepam-[applied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "diazepam-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "diazepam-[treats]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "diazepam-[treats or applied or studied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "diazepam-[applied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "diazepam-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "diazepam-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "nicotinic acid", "paths": ["nicotinic acid-[treats]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "nicotinic acid-[in clinical trials for]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "nicotinic acid-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "clonazepam", "paths": ["clonazepam-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "clonazepam-[applied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "clonazepam-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "clonazepam-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "clonazepam-[applied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "estradiol valerate", "paths": ["estradiol valerate-[in clinical trials for]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "estradiol valerate-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "estradiol valerate-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "Biological Products", "paths": ["Biological Products-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Biological Products-[treats or applied or studied to treat]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "acebutolol", "paths": ["acebutolol-[applied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "acebutolol-[in clinical trials for]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "acebutolol-[applied to treat]-mitral valve prolapse-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "acebutolol-[treats or applied or studied to treat]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "zolpidem", "paths": ["zolpidem-[applied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "zolpidem-[treats or applied or studied to treat]-Sleep abnormality-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "zolpidem-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "zolpidem-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "infliximab", "paths": ["infliximab-[in clinical trials for]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "infliximab-[treats or applied or studied to treat]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "infliximab-[in clinical trials for]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "human leukocyte interferon", "paths": ["human leukocyte interferon-[treats or applied or studied to treat]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "human leukocyte interferon-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "human leukocyte interferon-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "REBOXETINE", "paths": ["REBOXETINE-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "REBOXETINE-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "REBOXETINE-[in clinical trials for]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "Duration", "paths": ["Duration-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Duration-[treats or applied or studied to treat]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Duration-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "diflunisal", "paths": ["diflunisal-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "diflunisal-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "diflunisal-[treats]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "diflunisal-[in clinical trials for]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "diflunisal-[treats]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "sildenafil", "paths": ["sildenafil-[treats or applied or studied to treat]-Raynaud disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "sildenafil-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "sildenafil-[in clinical trials for]-Raynaud disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "hydroxyzine", "paths": ["hydroxyzine-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "hydroxyzine-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "hydroxyzine-[applied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "famotidine", "paths": ["famotidine-[treats or applied or studied to treat]-gastroesophageal reflux disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "famotidine-[in clinical trials for]-gastroesophageal reflux disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "famotidine-[applied to treat]-gastroesophageal reflux disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "famotidine-[in clinical trials for]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "famotidine-[treats]-gastroesophageal reflux disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "bisacodyl", "paths": ["bisacodyl-[regulates]-B4GALT7-[gene associated with condition]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "steroid", "paths": ["steroid-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "steroid-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "steroid-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "opioid analgesic", "paths": ["opioid analgesic-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "opioid analgesic-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "opioid analgesic-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "doxepin", "paths": ["doxepin-[treats]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "doxepin-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "doxepin-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "doxepin-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "doxepin-[treats]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "doxepin-[treats or applied or studied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "doxepin-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "minocycline", "paths": ["minocycline-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "minocycline-[applied to treat]-gingivitis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "minocycline-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "minocycline-[in clinical trials for]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "Hallucinogens", "paths": ["Hallucinogens-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Hallucinogens-[treats or applied or studied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Hallucinogens-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "carbamazepine", "paths": ["carbamazepine-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "carbamazepine-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "carbamazepine-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "carbamazepine-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "nabiximols", "paths": ["nabiximols-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "nabiximols-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "nabiximols-[treats or applied or studied to treat]-Nausea and vomiting-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "levodopa", "paths": ["levodopa-[in clinical trials for]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "levodopa-[treats or applied or studied to treat]-constipation disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "levodopa-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "Psychotropic Drugs", "paths": ["Psychotropic Drugs-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Psychotropic Drugs-[treats or applied or studied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Psychotropic Drugs-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "octreotide", "paths": ["octreotide-[in clinical trials for]-constipation disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "octreotide-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "octreotide-[in clinical trials for]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "BUPIVACAINE HYDROCHLORIDE", "paths": ["BUPIVACAINE HYDROCHLORIDE-[in clinical trials for]-Inguinal hernia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "BUPIVACAINE HYDROCHLORIDE-[in clinical trials for]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "BUPIVACAINE HYDROCHLORIDE-[in clinical trials for]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "acetazolamide", "paths": ["acetazolamide-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "acetazolamide-[treats or applied or studied to treat]-Apnea-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "acetazolamide-[in clinical trials for]-Apnea-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "acetazolamide-[in clinical trials for]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "Gotu kola", "paths": ["Gotu kola-[applied to treat]-venous insufficiency-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Gotu kola-[applied to treat]-severe cutaneous adverse reaction-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Gotu kola-[applied to treat]-Striae distensae-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "dimethyl sulfoxide", "paths": ["dimethyl sulfoxide-[in clinical trials for]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "dimethyl sulfoxide-[in clinical trials for]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "dimethyl sulfoxide-[applied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "dimethyl sulfoxide-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "dimethyl sulfoxide-[in clinical trials for]-Myalgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "Tumeric", "paths": ["Tumeric-[applied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Tumeric-[applied to treat]-gingivitis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Tumeric-[applied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "Lavandula", "paths": ["Lavandula-[applied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Lavandula-[applied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Lavandula-[applied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "lithium carbonate", "paths": ["lithium carbonate-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "lithium carbonate-[treats]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "lithium carbonate-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "lithium carbonate-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "lithium carbonate-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "esflurbiprofen", "paths": ["esflurbiprofen-[treats]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "esflurbiprofen-[in clinical trials for]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "esflurbiprofen-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "esflurbiprofen-[in clinical trials for]-Myalgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "tolmetin", "paths": ["tolmetin-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "tolmetin-[in clinical trials for]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "tolmetin-[in clinical trials for]-Myalgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "tolmetin-[in clinical trials for]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "tolmetin-[treats]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "piroxicam", "paths": ["piroxicam-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "piroxicam-[treats]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "piroxicam-[in clinical trials for]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "piroxicam-[in clinical trials for]-Myalgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "piroxicam-[in clinical trials for]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "flurbiprofen", "paths": ["flurbiprofen-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "flurbiprofen-[in clinical trials for]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "flurbiprofen-[treats]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "flurbiprofen-[in clinical trials for]-Myalgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "meclofenamic acid", "paths": ["meclofenamic acid-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "meclofenamic acid-[treats]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "meclofenamic acid-[in clinical trials for]-Myalgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "meclofenamic acid-[in clinical trials for]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "meclofenamic acid-[in clinical trials for]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "aceclofenac", "paths": ["aceclofenac-[in clinical trials for]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "aceclofenac-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "aceclofenac-[in clinical trials for]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "aceclofenac-[in clinical trials for]-Myalgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "aceclofenac-[treats]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "felbinac", "paths": ["felbinac-[in clinical trials for]-Myalgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "felbinac-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "felbinac-[treats]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "felbinac-[in clinical trials for]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "etofenamate", "paths": ["etofenamate-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "etofenamate-[in clinical trials for]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "etofenamate-[treats]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "etofenamate-[in clinical trials for]-Myalgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "curcumin", "paths": ["curcumin-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "curcumin-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "curcumin-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "(+)-menthol", "paths": ["(+)-menthol-[in clinical trials for]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "(+)-menthol-[in clinical trials for]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "(+)-menthol-[in clinical trials for]-Myalgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "quercetin", "paths": ["quercetin-[in clinical trials for]-gastroesophageal reflux disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "quercetin-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "quercetin-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "quercetin-[in clinical trials for]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "prednisolone", "paths": ["prednisolone-[treats or applied or studied to treat]-Muscle weakness-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "prednisolone-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "prednisolone-[treats or applied or studied to treat]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "prednisolone-[in clinical trials for]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "statin", "paths": ["statin-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "statin-[preventative for condition]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "statin-[preventative for condition]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "statin-[preventative for condition]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "statin-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "phenylbutazone", "paths": ["phenylbutazone-[in clinical trials for]-Myalgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "phenylbutazone-[in clinical trials for]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "phenylbutazone-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "nimesulide", "paths": ["nimesulide-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "nimesulide-[in clinical trials for]-Myalgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "nimesulide-[in clinical trials for]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "active ingredient", "paths": ["active ingredient-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "active ingredient-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "active ingredient-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "New medications", "paths": ["New medications-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "New medications-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "New medications-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "feprazone", "paths": ["feprazone-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "feprazone-[in clinical trials for]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "feprazone-[in clinical trials for]-Myalgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "CHEMBL.COMPOUND:CHEMBL5314358", "paths": ["CHEMBL.COMPOUND:CHEMBL5314358-[in clinical trials for]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "CHEMBL.COMPOUND:CHEMBL5314358-[in clinical trials for]-Raynaud disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "CHEMBL.COMPOUND:CHEMBL5314358-[in clinical trials for]-gastroesophageal reflux disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "reserpine", "paths": ["reserpine-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "reserpine-[treats or applied or studied to treat]-Raynaud disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "reserpine-[treats or applied or studied to treat]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "ethinylestradiol", "paths": ["ethinylestradiol-[in clinical trials for]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ethinylestradiol-[applied to treat]-Menometrorrhagia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ethinylestradiol-[applied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ethinylestradiol-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "piracetam", "paths": ["piracetam-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "piracetam-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "piracetam-[treats or applied or studied to treat]-central nervous system origin vertigo-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "thiethylperazine", "paths": ["thiethylperazine-[treats or applied or studied to treat]-Nausea and vomiting-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "thiethylperazine-[treats or applied or studied to treat]-central nervous system origin vertigo-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "thiethylperazine-[in clinical trials for]-Inguinal hernia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "thiethylperazine-[treats]-Nausea and vomiting-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "dexketoprofen", "paths": ["dexketoprofen-[in clinical trials for]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "dexketoprofen-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "dexketoprofen-[in clinical trials for]-Myalgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "desipramine", "paths": ["desipramine-[in clinical trials for]-gastroesophageal reflux disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "desipramine-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "desipramine-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "desipramine-[applied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "desipramine-[treats]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "PSILOCYBINE", "paths": ["PSILOCYBINE-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "PSILOCYBINE-[in clinical trials for]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "PSILOCYBINE-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "PSILOCYBINE-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "PSILOCYBINE-[treats or applied or studied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "perphenazine", "paths": ["perphenazine-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "perphenazine-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "perphenazine-[treats or applied or studied to treat]-Nausea and vomiting-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "perphenazine-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "perphenazine-[treats]-Nausea and vomiting-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "levetiracetam", "paths": ["levetiracetam-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "levetiracetam-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "levetiracetam-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "levetiracetam-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "perazine", "paths": ["perazine-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "perazine-[treats]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "perazine-[treats or applied or studied to treat]-Nausea and vomiting-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "perazine-[treats or applied or studied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "perazine-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "perazine-[treats]-Nausea and vomiting-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "clozapine", "paths": ["clozapine-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "clozapine-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "clozapine-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "clozapine-[treats or applied or studied to treat]-constipation disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "phenobarbital", "paths": ["phenobarbital-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "phenobarbital-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "phenobarbital-[treats]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "phenobarbital-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "theophylline", "paths": ["theophylline-[in clinical trials for]-Apnea-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "theophylline-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "theophylline-[treats or applied or studied to treat]-Apnea-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "theophylline-[preventative for condition]-Apnea-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "theophylline-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "theophylline-[treats or applied or studied to treat]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "oxytocin", "paths": ["oxytocin-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "oxytocin-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "oxytocin-[treats or applied or studied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "chlorpromazine", "paths": ["chlorpromazine-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "chlorpromazine-[treats or applied or studied to treat]-Nausea and vomiting-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "chlorpromazine-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "chlorpromazine-[treats]-Nausea and vomiting-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "Prescribed medications", "paths": ["Prescribed medications-[treats or applied or studied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Prescribed medications-[treats or applied or studied to treat]-gastroesophageal reflux disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Prescribed medications-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "sodium bicarbonate", "paths": ["sodium bicarbonate-[in clinical trials for]-gastroesophageal reflux disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "sodium bicarbonate-[treats or applied or studied to treat]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "sodium bicarbonate-[in clinical trials for]-constipation disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "atracurium", "paths": ["atracurium-[preventative for condition]-Myalgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "atracurium-[treats or applied or studied to treat]-Hypotonia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "isovaleryl-CoA", "paths": ["isovaleryl-CoA-[affects]-PECR-[gene associated with condition]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "armodafinil", "paths": ["armodafinil-[applied to treat]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "armodafinil-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "armodafinil-[in clinical trials for]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "METHYLPHENIDATE HYDROCHLORIDE", "paths": ["METHYLPHENIDATE HYDROCHLORIDE-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "METHYLPHENIDATE HYDROCHLORIDE-[in clinical trials for]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "METHYLPHENIDATE HYDROCHLORIDE-[applied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "modafinil", "paths": ["modafinil-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "modafinil-[preventative for condition]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "modafinil-[applied to treat]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "modafinil-[in clinical trials for]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "modafinil-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "modafinil-[treats or applied or studied to treat]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "polyvinyl alcohol", "paths": ["polyvinyl alcohol-[in clinical trials for]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "polyvinyl alcohol-[applied to treat]-xerophthalmia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "acetyl-L-carnitine", "paths": ["acetyl-L-carnitine-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "acetyl-L-carnitine-[applied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "acetyl-L-carnitine-[in clinical trials for]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "amantadine", "paths": ["amantadine-[preventative for condition]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "amantadine-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "amantadine-[treats or applied or studied to treat]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "Interferons", "paths": ["Interferons-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Interferons-[treats or applied or studied to treat]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "ribavirin", "paths": ["ribavirin-[treats or applied or studied to treat]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ribavirin-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ribavirin-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "Interferon-alpha", "paths": ["Interferon-alpha-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Interferon-alpha-[treats or applied or studied to treat]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "Psychostimulant (substance)", "paths": ["Psychostimulant (substance)-[treats or applied or studied to treat]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Psychostimulant (substance)-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "afatinib", "paths": ["afatinib-[regulates]-PECR-[gene associated with condition]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "tapentadol", "paths": ["tapentadol-[in clinical trials for]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "tapentadol-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "tapentadol-[in clinical trials for]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "FEPIXNEBART", "paths": ["FEPIXNEBART-[in clinical trials for]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "FEPIXNEBART-[in clinical trials for]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "ATB-346", "paths": ["ATB-346-[in clinical trials for]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ATB-346-[in clinical trials for]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "FULRANUMAB", "paths": ["FULRANUMAB-[in clinical trials for]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "FULRANUMAB-[in clinical trials for]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "ebaresdax", "paths": ["ebaresdax-[in clinical trials for]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ebaresdax-[in clinical trials for]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "etoricoxib", "paths": ["etoricoxib-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "etoricoxib-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "etoricoxib-[in clinical trials for]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "HYDROCODONE BITARTRATE", "paths": ["HYDROCODONE BITARTRATE-[in clinical trials for]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "HYDROCODONE BITARTRATE-[in clinical trials for]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "TANEZUMAB", "paths": ["TANEZUMAB-[in clinical trials for]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "TANEZUMAB-[in clinical trials for]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "Cyclooxygenase Inhibitors", "paths": ["Cyclooxygenase Inhibitors-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Cyclooxygenase Inhibitors-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "Analgesics, Non-Narcotic", "paths": ["Analgesics, Non-Narcotic-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Analgesics, Non-Narcotic-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "anashca", "paths": ["anashca-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "anashca-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "milnacipran", "paths": ["milnacipran-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "milnacipran-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "milnacipran-[applied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "milnacipran-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "Adjuvant Analgesic", "paths": ["Adjuvant Analgesic-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Adjuvant Analgesic-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "Atypical antipsychotic", "paths": ["Atypical antipsychotic-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Atypical antipsychotic-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "NMDA receptor antagonist", "paths": ["NMDA receptor antagonist-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "NMDA receptor antagonist-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "Medical Marijuana", "paths": ["Medical Marijuana-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Medical Marijuana-[treats or applied or studied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "hydromorphone", "paths": ["hydromorphone-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "hydromorphone-[in clinical trials for]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "hydromorphone-[in clinical trials for]-constipation disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "lubiprostone", "paths": ["lubiprostone-[applied to treat]-constipation disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "lubiprostone-[treats or applied or studied to treat]-constipation disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "lubiprostone-[in clinical trials for]-constipation disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "lubiprostone-[in clinical trials for]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "Narcotic Antagonists", "paths": ["Narcotic Antagonists-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Narcotic Antagonists-[treats or applied or studied to treat]-constipation disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "2-phenyl-benzopyrans", "paths": ["2-phenyl-benzopyrans-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "2-phenyl-benzopyrans-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "capsicum", "paths": ["capsicum-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "capsicum-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "LIDOCAINE HYDROCHLORIDE", "paths": ["LIDOCAINE HYDROCHLORIDE-[in clinical trials for]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "LIDOCAINE HYDROCHLORIDE-[in clinical trials for]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "N-palmitoylethanolamine", "paths": ["N-palmitoylethanolamine-[in clinical trials for]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "N-palmitoylethanolamine-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "metamizole", "paths": ["metamizole-[in clinical trials for]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "metamizole-[in clinical trials for]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "metamizole-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "Opiates", "paths": ["Opiates-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Opiates-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "Narcotics", "paths": ["Narcotics-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Narcotics-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "Drug Combinations", "paths": ["Drug Combinations-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Drug Combinations-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "mexiletine", "paths": ["mexiletine-[in clinical trials for]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "mexiletine-[treats or applied or studied to treat]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "mexiletine-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "mexiletine-[in clinical trials for]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "local anaesthetic", "paths": ["local anaesthetic-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "local anaesthetic-[treats or applied or studied to treat]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "Sodium Channel Blockers", "paths": ["Sodium Channel Blockers-[treats or applied or studied to treat]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Sodium Channel Blockers-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "AZD2066", "paths": ["AZD2066-[in clinical trials for]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "AZD2066-[in clinical trials for]-gastroesophageal reflux disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "(2E)-Dodecenoyl-CoA", "paths": ["(2E)-Dodecenoyl-CoA-[affects]-PECR-[gene associated with condition]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "ocriplasmin", "paths": ["ocriplasmin-[affects]-COL5A1-[gene associated with condition]-Ehlers-Danlos syndrome, hypermobility type", "ocriplasmin-[affects]-COL3A1-[gene associated with condition]-Ehlers-Danlos syndrome, hypermobility type", "ocriplasmin-[affects]-COL6A5-[gene associated with condition]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "iron", "paths": ["iron-[treats or applied or studied to treat]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "dabrafenib", "paths": ["dabrafenib-[regulates]-PECR-[gene associated with condition]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "METOPROLOL FUMARATE", "paths": ["METOPROLOL FUMARATE-[applied to treat]-mitral valve prolapse-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "tacrine", "paths": ["tacrine-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "tacrine-[treats or applied or studied to treat]-Joint dislocation-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "tacrine-[preventative for condition]-Joint dislocation-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "Onions", "paths": ["Onions-[applied to treat]-Striae distensae-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Onions-[applied to treat]-severe cutaneous adverse reaction-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "ROSE HIPS", "paths": ["ROSE HIPS-[applied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ROSE HIPS-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ROSE HIPS-[applied to treat]-Striae distensae-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "bevacizumab", "paths": ["bevacizumab-[treats or applied or studied to treat]-severe cutaneous adverse reaction-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "bevacizumab-[treats or applied or studied to treat]-Epistaxis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "Cod Liver Oil", "paths": ["Cod Liver Oil-[applied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Cod Liver Oil-[applied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "creatine", "paths": ["creatine-[applied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "creatine-[applied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "D-glucosamine", "paths": ["D-glucosamine-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "D-glucosamine-[preventative for condition]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "D-glucosamine-[in clinical trials for]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "D-glucosamine-[applied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "D-glucosamine-[treats or applied or studied to treat]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "nicotinamide", "paths": ["nicotinamide-[applied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "nicotinamide-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "Soybeans", "paths": ["Soybeans-[applied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Soybeans-[applied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "retinol", "paths": ["retinol-[preventative for condition]-xerophthalmia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "retinol-[applied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "retinol-[treats or applied or studied to treat]-xerophthalmia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "Ginger (dietary)", "paths": ["Ginger (dietary)-[applied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Ginger (dietary)-[applied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "Urtica", "paths": ["Urtica-[applied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Urtica-[applied to treat]-gingivitis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "black cohosh extract", "paths": ["black cohosh extract-[applied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "black cohosh extract-[applied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "choline", "paths": ["choline-[treats]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "choline-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "choline-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "rofecoxib", "paths": ["rofecoxib-[treats]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "rofecoxib-[treats]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "rofecoxib-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "rofecoxib-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "rofecoxib-[in clinical trials for]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "magnesium salicylate", "paths": ["magnesium salicylate-[treats or applied or studied to treat]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "magnesium salicylate-[treats]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "magnesium salicylate-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "magnesium salicylate-[treats]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "choline dehydrocholate", "paths": ["choline dehydrocholate-[treats or applied or studied to treat]-constipation disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "choline dehydrocholate-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "LIGUSTRAZINE", "paths": ["LIGUSTRAZINE-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "LIGUSTRAZINE-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "1,200 mg", "paths": ["1,200 mg-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "1,200 mg-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "3-rhamnosyl-glucosyl quercetin", "paths": ["3-rhamnosyl-glucosyl quercetin-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "3-rhamnosyl-glucosyl quercetin-[treats or applied or studied to treat]-venous insufficiency-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "vancomycin", "paths": ["vancomycin-[in clinical trials for]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "vancomycin-[in clinical trials for]-constipation disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "ROPIVACAINE HYDROCHLORIDE", "paths": ["ROPIVACAINE HYDROCHLORIDE-[in clinical trials for]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ROPIVACAINE HYDROCHLORIDE-[in clinical trials for]-Inguinal hernia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "rebamipide", "paths": ["rebamipide-[in clinical trials for]-gastroesophageal reflux disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "rebamipide-[in clinical trials for]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "CHEMBL.COMPOUND:CHEMBL5314366", "paths": ["CHEMBL.COMPOUND:CHEMBL5314366-[in clinical trials for]-gastroesophageal reflux disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "CHEMBL.COMPOUND:CHEMBL5314366-[in clinical trials for]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "polysaccharide", "paths": ["polysaccharide-[treats or applied or studied to treat]-constipation disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "polysaccharide-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "Diphosphonates", "paths": ["Diphosphonates-[preventative for condition]-lytic metastatic bone lesion-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Diphosphonates-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Diphosphonates-[treats or applied or studied to treat]-lytic metastatic bone lesion-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "glucocorticoid", "paths": ["glucocorticoid-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "glucocorticoid-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "leptin", "paths": ["leptin-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "leptin-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "resveratrol", "paths": ["resveratrol-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "resveratrol-[preventative for condition]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "resveratrol-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "polyphenol", "paths": ["polyphenol-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "polyphenol-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "Proton Pump Inhibitors", "paths": ["Proton Pump Inhibitors-[preventative for condition]-gastroesophageal reflux disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Proton Pump Inhibitors-[treats or applied or studied to treat]-gastroesophageal reflux disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Proton Pump Inhibitors-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "methionine", "paths": ["methionine-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "methionine-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "glucose", "paths": ["glucose-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "glucose-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "Clodronate", "paths": ["Clodronate-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Clodronate-[treats or applied or studied to treat]-lytic metastatic bone lesion-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "ORALIT", "paths": ["ORALIT-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ORALIT-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "prostaglandin", "paths": ["prostaglandin-[treats or applied or studied to treat]-Raynaud disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "prostaglandin-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "S-adenosylmethionine", "paths": ["S-adenosylmethionine-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "S-adenosylmethionine-[treats or applied or studied to treat]-osteoarthritis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "S-adenosylmethionine-[applied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "Anticoagulants", "paths": ["Anticoagulants-[treats or applied or studied to treat]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Anticoagulants-[treats or applied or studied to treat]-Arterial dissection-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "myo-inositol", "paths": ["myo-inositol-[applied to treat]-Raynaud disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "myo-inositol-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "myo-inositol-[applied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "Ginkgo <Ginkgoaceae>", "paths": ["Ginkgo <Ginkgoaceae>-[applied to treat]-Raynaud disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Ginkgo <Ginkgoaceae>-[applied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "ST. JOHN'S WORT", "paths": ["ST. JOHN'S WORT-[in clinical trials for]-Raynaud disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ST. JOHN'S WORT-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "cinnarizine", "paths": ["cinnarizine-[treats]-central nervous system origin vertigo-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "cinnarizine-[treats or applied or studied to treat]-central nervous system origin vertigo-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "cinnarizine-[in clinical trials for]-central nervous system origin vertigo-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "cinnarizine-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "dimenhydrinate", "paths": ["dimenhydrinate-[treats or applied or studied to treat]-Nausea and vomiting-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "dimenhydrinate-[in clinical trials for]-central nervous system origin vertigo-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "dimenhydrinate-[treats]-Nausea and vomiting-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "dimenhydrinate-[treats]-central nervous system origin vertigo-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "dimenhydrinate-[treats or applied or studied to treat]-central nervous system origin vertigo-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "DIPHENHYDRAMINE HYDROCHLORIDE", "paths": ["DIPHENHYDRAMINE HYDROCHLORIDE-[in clinical trials for]-central nervous system origin vertigo-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "DIPHENHYDRAMINE HYDROCHLORIDE-[applied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "flunarizine", "paths": ["flunarizine-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "flunarizine-[in clinical trials for]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "flunarizine-[preventative for condition]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "flunarizine-[treats or applied or studied to treat]-central nervous system origin vertigo-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "flunarizine-[in clinical trials for]-central nervous system origin vertigo-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "chlormezanone", "paths": ["chlormezanone-[treats or applied or studied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "chlormezanone-[treats]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "chlormezanone-[treats or applied or studied to treat]-Sleep abnormality-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "ramelteon", "paths": ["ramelteon-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ramelteon-[treats or applied or studied to treat]-Sleep abnormality-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "CLOFEZONE", "paths": ["CLOFEZONE-[in clinical trials for]-Myalgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "CLOFEZONE-[in clinical trials for]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "benzydamine", "paths": ["benzydamine-[in clinical trials for]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "benzydamine-[in clinical trials for]-Myalgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "OXYPHENBUTAZONE", "paths": ["OXYPHENBUTAZONE-[in clinical trials for]-Myalgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "OXYPHENBUTAZONE-[in clinical trials for]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "fentiazac", "paths": ["fentiazac-[in clinical trials for]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "fentiazac-[in clinical trials for]-Myalgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "IDROCILAMIDE", "paths": ["IDROCILAMIDE-[in clinical trials for]-Myalgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "IDROCILAMIDE-[in clinical trials for]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "piketoprofen", "paths": ["piketoprofen-[in clinical trials for]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "piketoprofen-[in clinical trials for]-Myalgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "mofebutazone", "paths": ["mofebutazone-[in clinical trials for]-Myalgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "mofebutazone-[in clinical trials for]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "bendazac", "paths": ["bendazac-[in clinical trials for]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "bendazac-[in clinical trials for]-Myalgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "loxoprofen", "paths": ["loxoprofen-[in clinical trials for]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "loxoprofen-[in clinical trials for]-Myalgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "tolazoline", "paths": ["tolazoline-[in clinical trials for]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "tolazoline-[in clinical trials for]-Myalgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "suxibuzone", "paths": ["suxibuzone-[in clinical trials for]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "suxibuzone-[in clinical trials for]-Myalgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "nifenazone", "paths": ["nifenazone-[in clinical trials for]-Myalgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "nifenazone-[in clinical trials for]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "zucapsaicin", "paths": ["zucapsaicin-[in clinical trials for]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "zucapsaicin-[in clinical trials for]-Myalgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "hydroxocobalamin", "paths": ["hydroxocobalamin-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "hydroxocobalamin-[in clinical trials for]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "hydroxocobalamin-[applied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "hydroxocobalamin-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "niflumic acid", "paths": ["niflumic acid-[in clinical trials for]-Myalgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "niflumic acid-[in clinical trials for]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "bufexamac", "paths": ["bufexamac-[in clinical trials for]-Myalgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "bufexamac-[in clinical trials for]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "tolperisone", "paths": ["tolperisone-[in clinical trials for]-Arthralgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "tolperisone-[in clinical trials for]-Myalgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "rosuvastatin", "paths": ["rosuvastatin-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "rosuvastatin-[treats or applied or studied to treat]-Myalgia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "fluvoxamine", "paths": ["fluvoxamine-[applied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "fluvoxamine-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "fluvoxamine-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "fluvoxamine-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "EPA", "paths": ["EPA-[preventative for condition]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "EPA-[applied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "EPA-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "EPA-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "5-hydroxy-L-tryptophan", "paths": ["5-hydroxy-L-tryptophan-[applied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "5-hydroxy-L-tryptophan-[applied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "5-hydroxy-L-tryptophan-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "5-hydroxy-L-tryptophan-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "docosahexaenoic acid", "paths": ["docosahexaenoic acid-[in clinical trials for]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "docosahexaenoic acid-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "docosahexaenoic acid-[applied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "docosahexaenoic acid-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "L-tryptophan", "paths": ["L-tryptophan-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "L-tryptophan-[applied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "L-tryptophan-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "L-tryptophan-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "zinc(0)", "paths": ["zinc(0)-[applied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "zinc(0)-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "zinc(0)-[applied to treat]-gingivitis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "trimipramine", "paths": ["trimipramine-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "trimipramine-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "trimipramine-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "trimipramine-[treats]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "maprotiline", "paths": ["maprotiline-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "maprotiline-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "maprotiline-[treats]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "maprotiline-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "moclobemide", "paths": ["moclobemide-[treats]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "moclobemide-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "moclobemide-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "moclobemide-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "ethyl loflazepate", "paths": ["ethyl loflazepate-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ethyl loflazepate-[treats]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ethyl loflazepate-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ethyl loflazepate-[treats or applied or studied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ethyl loflazepate-[treats]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "opipramol", "paths": ["opipramol-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "opipramol-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "opipramol-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "opipramol-[treats]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "mifepristone", "paths": ["mifepristone-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "mifepristone-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "mifepristone-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "Loflazepic acid", "paths": ["Loflazepic acid-[treats or applied or studied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Loflazepic acid-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "donepezil", "paths": ["donepezil-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "donepezil-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "donepezil-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "citrate", "paths": ["citrate-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "citrate-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "escitalopram", "paths": ["escitalopram-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "escitalopram-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "escitalopram-[preventative for condition]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "escitalopram-[applied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "escitalopram-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "escitalopram-[applied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "escitalopram-[treats or applied or studied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "Plant Preparations", "paths": ["Plant Preparations-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Plant Preparations-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "melatonin", "paths": ["melatonin-[treats or applied or studied to treat]-gastroesophageal reflux disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "melatonin-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "saline", "paths": ["saline-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "saline-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "co q10", "paths": ["co q10-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "co q10-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "DESIPRAMINE HYDROCHLORIDE", "paths": ["DESIPRAMINE HYDROCHLORIDE-[applied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "DESIPRAMINE HYDROCHLORIDE-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "pyritinol", "paths": ["pyritinol-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "pyritinol-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "sulpiride", "paths": ["sulpiride-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "sulpiride-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "sulpiride-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "oxaflozane", "paths": ["oxaflozane-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "oxaflozane-[treats or applied or studied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "oxaflozane-[treats]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "amisulpride", "paths": ["amisulpride-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "amisulpride-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "amisulpride-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "oxazepam", "paths": ["oxazepam-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "oxazepam-[treats]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "oxazepam-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "oxazepam-[treats or applied or studied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "acamprosate", "paths": ["acamprosate-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "acamprosate-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "prucalopride", "paths": ["prucalopride-[treats]-constipation disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "prucalopride-[in clinical trials for]-constipation disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "prucalopride-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "prucalopride-[treats or applied or studied to treat]-constipation disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "zaleplon", "paths": ["zaleplon-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "zaleplon-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "rivastigmine", "paths": ["rivastigmine-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "rivastigmine-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "nicergoline", "paths": ["nicergoline-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "nicergoline-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "nitrazepam", "paths": ["nitrazepam-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "nitrazepam-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "lormetazepam", "paths": ["lormetazepam-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "lormetazepam-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "amibegron", "paths": ["amibegron-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "amibegron-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "paliperidone", "paths": ["paliperidone-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "paliperidone-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "flupentixol", "paths": ["flupentixol-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "flupentixol-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "flupentixol-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "zuclopenthixol", "paths": ["zuclopenthixol-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "zuclopenthixol-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "VITAMIN E", "paths": ["VITAMIN E-[in clinical trials for]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "VITAMIN E-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "biperiden", "paths": ["biperiden-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "biperiden-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "TRANYLCYPROMINE", "paths": ["TRANYLCYPROMINE-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "TRANYLCYPROMINE-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "nelivaptan", "paths": ["nelivaptan-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "nelivaptan-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "pimozide", "paths": ["pimozide-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "pimozide-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "flurazepam", "paths": ["flurazepam-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "flurazepam-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "(-)-noradrenaline", "paths": ["(-)-noradrenaline-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "(-)-noradrenaline-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "(-)-noradrenaline-[preventative for condition]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "levomepromazine", "paths": ["levomepromazine-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "levomepromazine-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "TC-2216", "paths": ["TC-2216-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "TC-2216-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "ziprasidone", "paths": ["ziprasidone-[applied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ziprasidone-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ziprasidone-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ziprasidone-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "pindolol", "paths": ["pindolol-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "pindolol-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "pindolol-[treats or applied or studied to treat]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "IMIPRAMINE HYDROCHLORIDE", "paths": ["IMIPRAMINE HYDROCHLORIDE-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "IMIPRAMINE HYDROCHLORIDE-[applied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "chloral hydrate", "paths": ["chloral hydrate-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "chloral hydrate-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "pivagabine", "paths": ["pivagabine-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "pivagabine-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "ethosuximide", "paths": ["ethosuximide-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "ethosuximide-[in clinical trials for]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "oxcarbazepine", "paths": ["oxcarbazepine-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "oxcarbazepine-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "sertindole", "paths": ["sertindole-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "sertindole-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "DONEPEZIL HYDROCHLORIDE", "paths": ["DONEPEZIL HYDROCHLORIDE-[in clinical trials for]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "DONEPEZIL HYDROCHLORIDE-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "clobazam", "paths": ["clobazam-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "clobazam-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "brotizolam", "paths": ["brotizolam-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "brotizolam-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "bromazepam", "paths": ["bromazepam-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "bromazepam-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "chlorprothixene", "paths": ["chlorprothixene-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "chlorprothixene-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "tiapride", "paths": ["tiapride-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "tiapride-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "melperone", "paths": ["melperone-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "melperone-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "zopiclone", "paths": ["zopiclone-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "zopiclone-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "mianserin", "paths": ["mianserin-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "mianserin-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "mianserin-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "agomelatine", "paths": ["agomelatine-[treats or applied or studied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "agomelatine-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "agomelatine-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "agomelatine-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "galantamine", "paths": ["galantamine-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "galantamine-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "bromperidol", "paths": ["bromperidol-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "bromperidol-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "SAREDUTANT", "paths": ["SAREDUTANT-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "SAREDUTANT-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "vortioxetine", "paths": ["vortioxetine-[applied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "vortioxetine-[applied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "vortioxetine-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "vortioxetine-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "fluphenazine", "paths": ["fluphenazine-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "fluphenazine-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "fluspirilene", "paths": ["fluspirilene-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "fluspirilene-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "vilazodone", "paths": ["vilazodone-[applied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "vilazodone-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "vilazodone-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "vilazodone-[applied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "triazolam", "paths": ["triazolam-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "triazolam-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "prothipendyl", "paths": ["prothipendyl-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "prothipendyl-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "pipamperone", "paths": ["pipamperone-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "pipamperone-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "benperidol", "paths": ["benperidol-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "benperidol-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "clomethiazole", "paths": ["clomethiazole-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "clomethiazole-[in clinical trials for]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "Insulin", "paths": ["Insulin-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Insulin-[treats or applied or studied to treat]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "argipressin", "paths": ["argipressin-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "argipressin-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "Selective Serotonin Reuptake Inhibitors", "paths": ["Selective Serotonin Reuptake Inhibitors-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Selective Serotonin Reuptake Inhibitors-[preventative for condition]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Selective Serotonin Reuptake Inhibitors-[treats or applied or studied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "bromocriptine", "paths": ["bromocriptine-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "bromocriptine-[treats or applied or studied to treat]-Decreased fertility-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "nimodipine", "paths": ["nimodipine-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "nimodipine-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "MDMA", "paths": ["MDMA-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "MDMA-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "4,4'-Diamino-2,2'-stilbenedisulfonic acid", "paths": ["4,4'-Diamino-2,2'-stilbenedisulfonic acid-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "4,4'-Diamino-2,2'-stilbenedisulfonic acid-[treats or applied or studied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "Lysergide", "paths": ["Lysergide-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Lysergide-[treats or applied or studied to treat]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Lysergide-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "isoprenaline", "paths": ["isoprenaline-[treats or applied or studied to treat]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "isoprenaline-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "Serotonin Agonists", "paths": ["Serotonin Agonists-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Serotonin Agonists-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "Antiepileptic Agents", "paths": ["Antiepileptic Agents-[preventative for condition]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Antiepileptic Agents-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Antiepileptic Agents-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "Contraceptives, Oral", "paths": ["Contraceptives, Oral-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Contraceptives, Oral-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "Prescription Drugs", "paths": ["Prescription Drugs-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Prescription Drugs-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "growth hormone", "paths": ["growth hormone-[treats or applied or studied to treat]-scoliosis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "growth hormone-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "adenosine 5'-monophosphate", "paths": ["adenosine 5'-monophosphate-[preventative for condition]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "adenosine 5'-monophosphate-[treats or applied or studied to treat]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "adenosine 5'-monophosphate-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "flumazenil", "paths": ["flumazenil-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "flumazenil-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "arginine", "paths": ["arginine-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "arginine-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "arginine-[applied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "Excitatory Amino Acid Antagonists", "paths": ["Excitatory Amino Acid Antagonists-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Excitatory Amino Acid Antagonists-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "atropine", "paths": ["atropine-[treats or applied or studied to treat]-depressive disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "atropine-[treats or applied or studied to treat]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "atropine-[preventative for condition]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "loxapine", "paths": ["loxapine-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "loxapine-[in clinical trials for]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "butorphanol", "paths": ["butorphanol-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "butorphanol-[in clinical trials for]-anxiety-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "butorphanol-[applied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "OLANZAPINE PAMOATE", "paths": ["OLANZAPINE PAMOATE-[applied to treat]-Nausea and vomiting-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "OLANZAPINE PAMOATE-[applied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "domperidone", "paths": ["domperidone-[in clinical trials for]-gastroesophageal reflux disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "domperidone-[treats]-Nausea and vomiting-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "domperidone-[treats or applied or studied to treat]-Nausea and vomiting-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "domperidone-[treats or applied or studied to treat]-gastroesophageal reflux disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "Antiemetics", "paths": ["Antiemetics-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Antiemetics-[preventative for condition]-Nausea and vomiting-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Antiemetics-[treats or applied or studied to treat]-Nausea and vomiting-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "macrogol", "paths": ["macrogol-[applied to treat]-xerophthalmia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "macrogol-[treats]-constipation disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "macrogol-[applied to treat]-constipation disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "macrogol-[in clinical trials for]-constipation disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "macrogol-[treats or applied or studied to treat]-constipation disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "magnesium carbonate", "paths": ["magnesium carbonate-[treats]-gastroesophageal reflux disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "magnesium carbonate-[treats or applied or studied to treat]-gastroesophageal reflux disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "magnesium carbonate-[treats]-constipation disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "magnesium carbonate-[in clinical trials for]-constipation disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "magnesium carbonate-[treats or applied or studied to treat]-constipation disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "TEGASEROD", "paths": ["TEGASEROD-[treats or applied or studied to treat]-constipation disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "TEGASEROD-[in clinical trials for]-gastroesophageal reflux disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "TEGASEROD-[in clinical trials for]-constipation disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "mosapride", "paths": ["mosapride-[treats or applied or studied to treat]-gastroesophageal reflux disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "mosapride-[in clinical trials for]-constipation disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "propylene glycol", "paths": ["propylene glycol-[in clinical trials for]-constipation disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "propylene glycol-[applied to treat]-xerophthalmia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "cisapride", "paths": ["cisapride-[preventative for condition]-gastroesophageal reflux disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "cisapride-[treats]-gastroesophageal reflux disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "cisapride-[treats or applied or studied to treat]-constipation disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "cisapride-[treats or applied or studied to treat]-gastroesophageal reflux disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "prokinetic agent", "paths": ["prokinetic agent-[treats or applied or studied to treat]-constipation disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "prokinetic agent-[treats or applied or studied to treat]-gastroesophageal reflux disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "Sanguinaria canadensis", "paths": ["Sanguinaria canadensis-[applied to treat]-gingivitis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Sanguinaria canadensis-[applied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "RASEGLURANT", "paths": ["RASEGLURANT-[in clinical trials for]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "RASEGLURANT-[in clinical trials for]-gastroesophageal reflux disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "progestin", "paths": ["progestin-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "progestin-[treats or applied or studied to treat]-Decreased fertility-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "Angiotensin-Converting Enzyme Inhibitors", "paths": ["Angiotensin-Converting Enzyme Inhibitors-[preventative for condition]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Angiotensin-Converting Enzyme Inhibitors-[treats or applied or studied to treat]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "Angiotensin-Converting Enzyme Inhibitors-[preventative for condition]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "pethidine", "paths": ["pethidine-[in clinical trials for]-scoliosis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "pethidine-[treats or applied or studied to treat]-migraine disorder-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "cefazolin", "paths": ["cefazolin-[in clinical trials for]-Inguinal hernia-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "cefazolin-[in clinical trials for]-cardiac rhythm disease-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "alfacalcidol", "paths": ["alfacalcidol-[in clinical trials for]-scoliosis-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "alfacalcidol-[in clinical trials for]-pelvic organ prolapse-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "dactinomycin", "paths": ["dactinomycin-[regulates]-COL3A1-[gene associated with condition]-Ehlers-Danlos syndrome, hypermobility type", "dactinomycin-[affects]-HTT-[physically interacts with]-TMEM43-[gene associated with condition]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "benzoic acid", "paths": ["benzoic acid-[applied to treat]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "1,2-DIBROMOETHANE", "paths": ["1,2-DIBROMOETHANE-[affects]-GSTM5-[gene associated with condition]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "oxymorphone", "paths": ["oxymorphone-[treats]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "oxymorphone-[in clinical trials for]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "oxymorphone-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "(1S,2R)-naphthalene 1,2-oxide", "paths": ["(1S,2R)-naphthalene 1,2-oxide-[affects]-GSTM5-[gene associated with condition]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "cyclophosphamide", "paths": ["cyclophosphamide-[affects]-glutathione-[physically interacts with]-GSTM5-[gene associated with condition]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "CHARCOAL, ACTIVATED", "paths": ["CHARCOAL, ACTIVATED-[part of]-nucleus pulposus-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "CHARCOAL, ACTIVATED-[part of]-intervertebral disk of atlas-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "CHARCOAL, ACTIVATED-[part of]-intervertebral disk of seventh cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "CHARCOAL, ACTIVATED-[part of]-proteoglycan-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "CHARCOAL, ACTIVATED-[part of]-intervertebral disk of cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "CHARCOAL, ACTIVATED-[part of]-intervertebral disk of third cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "CHARCOAL, ACTIVATED-[part of]-intervertebral disk of sixth cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "CHARCOAL, ACTIVATED-[part of]-intervertebral disk of fifth cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "CHARCOAL, ACTIVATED-[part of]-intervertebral disk of thoracic vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "CHARCOAL, ACTIVATED-[part of]-DEXPROPRANOLOL HYDROCHLORIDE-[has part]-propranolol-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "CHARCOAL, ACTIVATED-[part of]-Anaerocult(TM)-[has part]-silicon dioxide-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "CHARCOAL, ACTIVATED-[part of]-intervertebral disk of fourth cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "CHARCOAL, ACTIVATED-[part of]-intervertebral disk of lumbar vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "CHARCOAL, ACTIVATED-[part of]-schreckstoff-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "CHARCOAL, ACTIVATED-[part of]-intervertebral disk of axis-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "CHARCOAL, ACTIVATED-[part of]-PROPRANOLOL HYDROCHLORIDE-[has part]-propranolol-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "CHARCOAL, ACTIVATED-[part of]-intervertebral disk of sacral vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "CHARCOAL, ACTIVATED-[part of]-tail intervertebral disc-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "nitrogen", "paths": ["nitrogen-[part of]-intervertebral disk of seventh cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "nitrogen-[part of]-intervertebral disk of third cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "nitrogen-[part of]-DEXPROPRANOLOL HYDROCHLORIDE-[has part]-propranolol-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "nitrogen-[part of]-intervertebral disk of thoracic vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "nitrogen-[part of]-intervertebral disk of fifth cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "nitrogen-[part of]-PROPRANOLOL HYDROCHLORIDE-[has part]-propranolol-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "nitrogen-[part of]-intervertebral disk of axis-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "nitrogen-[part of]-nucleus pulposus-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "nitrogen-[part of]-intervertebral disk of cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "nitrogen-[part of]-intervertebral disk of sixth cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "nitrogen-[part of]-schreckstoff-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "nitrogen-[part of]-tail intervertebral disc-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "nitrogen-[part of]-intervertebral disk of sacral vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "nitrogen-[part of]-intervertebral disk of fourth cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "nitrogen-[part of]-intervertebral disk of atlas-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "nitrogen-[part of]-proteoglycan-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "nitrogen-[part of]-intervertebral disk of lumbar vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "glycosaminoglycan", "paths": ["glycosaminoglycan-[part of]-intervertebral disk of third cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "glycosaminoglycan-[part of]-intervertebral disk of seventh cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "glycosaminoglycan-[part of]-intervertebral disk of sixth cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "glycosaminoglycan-[part of]-intervertebral disk of fifth cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "glycosaminoglycan-[part of]-intervertebral disk of cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "glycosaminoglycan-[is input of]-chondroitin sulfate binding-[has input]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "glycosaminoglycan-[is output of]-chondroitin sulfate biosynthetic process-[has output]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "glycosaminoglycan-[part of]-intervertebral disk of fourth cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "glycosaminoglycan-[part of]-intervertebral disk of lumbar vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "glycosaminoglycan-[part of]-intervertebral disk of axis-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "glycosaminoglycan-[part of]-intervertebral disk of atlas-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "glycosaminoglycan-[part of]-intervertebral disk of thoracic vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "glycosaminoglycan-[part of]-nucleus pulposus-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "glycosaminoglycan-[part of]-tail intervertebral disc-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "glycosaminoglycan-[part of]-schreckstoff-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "glycosaminoglycan-[part of]-cartilage tissue-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "glycosaminoglycan-[is input of]-chondroitin sulfate catabolic process-[has input]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "glycosaminoglycan-[part of]-intervertebral disk of sacral vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "acryloyl-CoA", "paths": ["acryloyl-CoA-[affects]-PECR-[gene associated with condition]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "2,2-Dichloroacetaldehyde", "paths": ["2,2-Dichloroacetaldehyde-[affects]-GSTM5-[gene associated with condition]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "sulfates", "paths": ["sulfates-[part of]-intervertebral disk of thoracic vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfates-[part of]-intervertebral disk of lumbar vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfates-[part of]-intervertebral disk of atlas-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfates-[is input of]-chondroitin sulfate binding-[has input]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfates-[part of]-intervertebral disk of fifth cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfates-[part of]-intervertebral disk of sixth cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfates-[part of]-schreckstoff-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfates-[part of]-intervertebral disk of fourth cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfates-[part of]-intervertebral disk of cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfates-[part of]-nucleus pulposus-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfates-[part of]-intervertebral disk of third cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfates-[is input of]-chondroitin sulfate catabolic process-[has input]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfates-[is output of]-chondroitin sulfate biosynthetic process-[has output]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfates-[part of]-intervertebral disk of seventh cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfates-[part of]-intervertebral disk of sacral vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfates-[part of]-tail intervertebral disc-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfates-[part of]-intervertebral disk of axis-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "sulfated glycosaminoglycan", "paths": ["sulfated glycosaminoglycan-[is input of]-chondroitin sulfate catabolic process-[has input]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfated glycosaminoglycan-[part of]-nucleus pulposus-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfated glycosaminoglycan-[part of]-intervertebral disk of fifth cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfated glycosaminoglycan-[part of]-intervertebral disk of axis-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfated glycosaminoglycan-[is output of]-chondroitin sulfate biosynthetic process-[has output]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfated glycosaminoglycan-[part of]-intervertebral disk of third cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfated glycosaminoglycan-[part of]-schreckstoff-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfated glycosaminoglycan-[part of]-intervertebral disk of lumbar vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfated glycosaminoglycan-[part of]-intervertebral disk of seventh cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfated glycosaminoglycan-[part of]-intervertebral disk of sixth cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfated glycosaminoglycan-[part of]-intervertebral disk of thoracic vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfated glycosaminoglycan-[part of]-tail intervertebral disc-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfated glycosaminoglycan-[part of]-intervertebral disk of cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfated glycosaminoglycan-[part of]-intervertebral disk of atlas-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfated glycosaminoglycan-[part of]-intervertebral disk of sacral vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfated glycosaminoglycan-[is input of]-chondroitin sulfate binding-[has input]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfated glycosaminoglycan-[part of]-intervertebral disk of fourth cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "mucopolysaccharide", "paths": ["mucopolysaccharide-[part of]-intervertebral disk of lumbar vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "mucopolysaccharide-[part of]-nucleus pulposus-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "mucopolysaccharide-[part of]-schreckstoff-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "mucopolysaccharide-[part of]-intervertebral disk of axis-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "mucopolysaccharide-[part of]-intervertebral disk of sixth cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "mucopolysaccharide-[part of]-intervertebral disk of fifth cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "mucopolysaccharide-[part of]-intervertebral disk of atlas-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "mucopolysaccharide-[part of]-tail intervertebral disc-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "mucopolysaccharide-[part of]-intervertebral disk of third cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "mucopolysaccharide-[is input of]-chondroitin sulfate catabolic process-[has input]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "mucopolysaccharide-[part of]-intervertebral disk of thoracic vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "mucopolysaccharide-[part of]-intervertebral disk of cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "mucopolysaccharide-[is output of]-chondroitin sulfate biosynthetic process-[has output]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "mucopolysaccharide-[is input of]-chondroitin sulfate binding-[has input]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "mucopolysaccharide-[part of]-intervertebral disk of seventh cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "mucopolysaccharide-[part of]-intervertebral disk of sacral vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "mucopolysaccharide-[part of]-intervertebral disk of fourth cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "glycan", "paths": ["glycan-[part of]-nucleus pulposus-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "glycan-[part of]-intervertebral disk of third cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "glycan-[is output of]-chondroitin sulfate biosynthetic process-[has output]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "glycan-[is input of]-chondroitin sulfate catabolic process-[has input]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "glycan-[part of]-intervertebral disk of seventh cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "glycan-[part of]-intervertebral disk of fifth cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "glycan-[part of]-tail intervertebral disc-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "glycan-[part of]-schreckstoff-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "glycan-[part of]-intervertebral disk of sixth cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "glycan-[part of]-intervertebral disk of axis-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "glycan-[part of]-intervertebral disk of sacral vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "glycan-[part of]-intervertebral disk of thoracic vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "glycan-[part of]-intervertebral disk of fourth cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "glycan-[is input of]-chondroitin sulfate binding-[has input]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "glycan-[part of]-intervertebral disk of atlas-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "glycan-[part of]-intervertebral disk of lumbar vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "glycan-[part of]-intervertebral disk of cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "organic sulfate", "paths": ["organic sulfate-[part of]-intervertebral disk of third cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "organic sulfate-[part of]-intervertebral disk of cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "organic sulfate-[part of]-intervertebral disk of sixth cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "organic sulfate-[part of]-intervertebral disk of lumbar vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "organic sulfate-[is input of]-chondroitin sulfate catabolic process-[has input]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "organic sulfate-[part of]-tail intervertebral disc-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "organic sulfate-[part of]-nucleus pulposus-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "organic sulfate-[part of]-intervertebral disk of seventh cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "organic sulfate-[is input of]-chondroitin sulfate binding-[has input]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "organic sulfate-[is output of]-chondroitin sulfate biosynthetic process-[has output]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "organic sulfate-[part of]-intervertebral disk of sacral vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "organic sulfate-[part of]-intervertebral disk of thoracic vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "organic sulfate-[part of]-schreckstoff-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "organic sulfate-[part of]-intervertebral disk of fifth cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "organic sulfate-[part of]-intervertebral disk of atlas-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "organic sulfate-[part of]-intervertebral disk of fourth cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "organic sulfate-[part of]-intervertebral disk of axis-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "carbohydrate sulfate", "paths": ["carbohydrate sulfate-[is output of]-chondroitin sulfate biosynthetic process-[has output]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "carbohydrate sulfate-[part of]-schreckstoff-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "carbohydrate sulfate-[part of]-nucleus pulposus-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "carbohydrate sulfate-[part of]-intervertebral disk of third cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "carbohydrate sulfate-[part of]-intervertebral disk of seventh cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "carbohydrate sulfate-[part of]-intervertebral disk of atlas-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "carbohydrate sulfate-[is input of]-chondroitin sulfate binding-[has input]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "carbohydrate sulfate-[part of]-intervertebral disk of axis-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "carbohydrate sulfate-[part of]-intervertebral disk of thoracic vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "carbohydrate sulfate-[part of]-intervertebral disk of sacral vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "carbohydrate sulfate-[part of]-intervertebral disk of fifth cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "carbohydrate sulfate-[part of]-intervertebral disk of cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "carbohydrate sulfate-[part of]-intervertebral disk of sixth cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "carbohydrate sulfate-[part of]-intervertebral disk of lumbar vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "carbohydrate sulfate-[part of]-tail intervertebral disc-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "carbohydrate sulfate-[is input of]-chondroitin sulfate catabolic process-[has input]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "carbohydrate sulfate-[part of]-intervertebral disk of fourth cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "collagenase", "paths": ["collagenase-[affects]-COL5A1-[gene associated with condition]-Ehlers-Danlos syndrome, hypermobility type", "collagenase-[affects]-COL3A1-[gene associated with condition]-Ehlers-Danlos syndrome, hypermobility type", "collagenase-[affects]-COL6A5-[gene associated with condition]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "sulfur", "paths": ["sulfur-[part of]-intervertebral disk of lumbar vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfur-[part of]-tail intervertebral disc-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfur-[part of]-intervertebral disk of sacral vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfur-[part of]-nucleus pulposus-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfur-[part of]-intervertebral disk of sixth cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfur-[part of]-intervertebral disk of cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfur-[part of]-intervertebral disk of fourth cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfur-[part of]-intervertebral disk of atlas-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfur-[part of]-intervertebral disk of third cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfur-[part of]-schreckstoff-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfur-[part of]-intervertebral disk of axis-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfur-[part of]-intervertebral disk of seventh cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfur-[part of]-intervertebral disk of fifth cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfur-[part of]-intervertebral disk of thoracic vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "keratan sulfate", "paths": ["keratan sulfate-[part of]-intervertebral disk of third cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "keratan sulfate-[part of]-intervertebral disk of lumbar vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "keratan sulfate-[part of]-intervertebral disk of atlas-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "keratan sulfate-[part of]-intervertebral disk of sacral vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "keratan sulfate-[part of]-intervertebral disk of seventh cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "keratan sulfate-[part of]-intervertebral disk of axis-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "keratan sulfate-[part of]-intervertebral disk of fifth cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "keratan sulfate-[part of]-intervertebral disk of cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "keratan sulfate-[part of]-tail intervertebral disc-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "keratan sulfate-[part of]-intervertebral disk of fourth cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "keratan sulfate-[part of]-intervertebral disk of sixth cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "keratan sulfate-[part of]-nucleus pulposus-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "keratan sulfate-[part of]-intervertebral disk of thoracic vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "sulfonyl group", "paths": ["sulfonyl group-[has active ingredient]-glucosamine / hyaluronate / methylsulfonylmethane-[has active ingredient]-METHANESULFONYLMETHANE-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfonyl group-[has active ingredient]-camphor / menthol / methyl salicylate / methylsulfonylmethane-[has active ingredient]-METHANESULFONYLMETHANE-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfonyl group-[has active ingredient]-chondroitin sulfates / glucosamine / hyaluronate / methylsulfonylmethane-[has active ingredient]-METHANESULFONYLMETHANE-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfonyl group-[has active ingredient]-methylsulfonylmethane / molybdenum-[has active ingredient]-METHANESULFONYLMETHANE-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfonyl group-[has active ingredient]-GLUCOSAMINE/METHYLSULFONYLMETHANE-[has active ingredient]-METHANESULFONYLMETHANE-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfonyl group-[has active ingredient]-RXCUI:1007537-[has active ingredient]-METHANESULFONYLMETHANE-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfonyl group-[has active ingredient]-chondroitin sulfates / glucosamine / methylsulfonylmethane / tocopherol-[has active ingredient]-METHANESULFONYLMETHANE-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "sufinpyrazone", "paths": ["sufinpyrazone-[regulates]-PECR-[gene associated with condition]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "idarubicin", "paths": ["idarubicin-[regulates]-COL3A1-[gene associated with condition]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "aldehydo-D-glucosamine", "paths": ["aldehydo-D-glucosamine-[has active ingredient]-chondroitin sulfates / glucosamine / methylsulfonylmethane / tocopherol-[has active ingredient]-METHANESULFONYLMETHANE-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "aldehydo-D-glucosamine-[has active ingredient]-glucosamine / hyaluronate / methylsulfonylmethane-[has active ingredient]-METHANESULFONYLMETHANE-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "aldehydo-D-glucosamine-[has active ingredient]-RXCUI:1007537-[has active ingredient]-METHANESULFONYLMETHANE-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "aldehydo-D-glucosamine-[has active ingredient]-GLUCOSAMINE/METHYLSULFONYLMETHANE-[has active ingredient]-METHANESULFONYLMETHANE-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "aldehydo-D-glucosamine-[has active ingredient]-chondroitin sulfates / glucosamine / hyaluronate / methylsulfonylmethane-[has active ingredient]-METHANESULFONYLMETHANE-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "tienilic acid", "paths": ["tienilic acid-[has part]-water-[part of]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "tienilic acid-[has part]-SULFUR, PRECIPITATED-[part of]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "tienilic acid-[has part]-water-[part of]-silicon dioxide-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "tienilic acid-[has part]-SULFUR, PRECIPITATED-[part of]-METHANESULFONYLMETHANE-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "tienilic acid-[has part]-water-[part of]-propranolol-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "tienilic acid-[has part]-hydrogen(.)-[part of]-propranolol-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "tienilic acid-[has part]-hydrogen(.)-[part of]-silicon dioxide-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "silicon molecular entity", "paths": ["silicon molecular entity-[is input of]-response to silicon dioxide-[has input]-silicon dioxide-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "silicon molecular entity-[is input of]-silicate transmembrane transporter activity-[has input]-silicon dioxide-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "silicon molecular entity-[part of]-hydrated silica-[has part]-silicon dioxide-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "silicon molecular entity-[is input of]-silicic acid import across plasma membrane-[has input]-silicon dioxide-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "silicon molecular entity-[part of]-Anaerocult(TM)-[has part]-silicon dioxide-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "(2E)-Octenoyl-CoA", "paths": ["(2E)-Octenoyl-CoA-[affects]-PECR-[gene associated with condition]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "oxide", "paths": ["oxide-[is input of]-response to silicon dioxide-[has input]-silicon dioxide-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "oxide-[part of]-hydrated silica-[has part]-silicon dioxide-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "oxide-[part of]-schreckstoff-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "oxide-[part of]-Anaerocult(TM)-[has part]-silicon dioxide-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "(1R)-Hydroxy-(2R)-glutathionyl-1,2-dihydronaphthalene", "paths": ["(1R)-Hydroxy-(2R)-glutathionyl-1,2-dihydronaphthalene-[affects]-GSTM5-[gene associated with condition]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "crizotinib", "paths": ["crizotinib-[regulates]-TNXB-[gene associated with condition]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "naphthalene 1,2-oxide", "paths": ["naphthalene 1,2-oxide-[affects]-GSTM5-[gene associated with condition]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "daunorubicin", "paths": ["daunorubicin-[regulates]-COL3A1-[gene associated with condition]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "METOPROLOL SUCCINATE", "paths": ["METOPROLOL SUCCINATE-[applied to treat]-mitral valve prolapse-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "S-(2,2-Dichloro-1-hydroxy)ethyl glutathione", "paths": ["S-(2,2-Dichloro-1-hydroxy)ethyl glutathione-[affects]-GSTM5-[gene associated with condition]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "GINSENG, ASIAN", "paths": ["GINSENG, ASIAN-[in clinical trials for]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "docetaxel", "paths": ["docetaxel-[in clinical trials for]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "ANAMORELIN HYDROCHLORIDE", "paths": ["ANAMORELIN HYDROCHLORIDE-[in clinical trials for]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "erythropoietin", "paths": ["erythropoietin-[in clinical trials for]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "erythropoietin-[treats or applied or studied to treat]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "CLAZAKIZUMAB", "paths": ["CLAZAKIZUMAB-[in clinical trials for]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "disulfiram", "paths": ["disulfiram-[in clinical trials for]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "pemoline", "paths": ["pemoline-[treats or applied or studied to treat]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "juzentaihoto", "paths": ["juzentaihoto-[treats or applied or studied to treat]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "eculizumab", "paths": ["eculizumab-[treats or applied or studied to treat]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "Antirheumatic Drugs, Disease-Modifying", "paths": ["Antirheumatic Drugs, Disease-Modifying-[treats or applied or studied to treat]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "glatiramer acetate", "paths": ["glatiramer acetate-[treats or applied or studied to treat]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "Immunomodulators", "paths": ["Immunomodulators-[treats or applied or studied to treat]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "monoclonal antibody AN100226", "paths": ["monoclonal antibody AN100226-[treats or applied or studied to treat]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "rituximab", "paths": ["rituximab-[treats or applied or studied to treat]-Fatigue-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "(2E)-Tetradecenoyl-CoA", "paths": ["(2E)-Tetradecenoyl-CoA-[affects]-PECR-[gene associated with condition]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "\u03c9-conotoxin MVIIA", "paths": ["\u03c9-conotoxin MVIIA-[treats]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type", "\u03c9-conotoxin MVIIA-[treats or applied or studied to treat]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "sufentanil", "paths": ["sufentanil-[in clinical trials for]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "PF-04457845", "paths": ["PF-04457845-[in clinical trials for]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "TRAMADOL HYDROCHLORIDE", "paths": ["TRAMADOL HYDROCHLORIDE-[in clinical trials for]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "prilocaine", "paths": ["prilocaine-[in clinical trials for]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "HYDROMORPHONE HYDROCHLORIDE", "paths": ["HYDROMORPHONE HYDROCHLORIDE-[in clinical trials for]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "KETOTIFEN FUMARATE", "paths": ["KETOTIFEN FUMARATE-[in clinical trials for]-Chronic pain-[phenotype of]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "ester", "paths": ["ester-[is input of]-chondroitin sulfate catabolic process-[has input]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "ester-[part of]-intervertebral disk of seventh cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "ester-[part of]-intervertebral disk of lumbar vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "ester-[part of]-intervertebral disk of cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "ester-[part of]-intervertebral disk of sixth cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "ester-[is output of]-chondroitin sulfate biosynthetic process-[has output]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "ester-[part of]-schreckstoff-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "ester-[part of]-intervertebral disk of atlas-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "ester-[part of]-intervertebral disk of axis-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "ester-[part of]-intervertebral disk of fourth cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "ester-[part of]-intervertebral disk of sacral vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "ester-[part of]-intervertebral disk of fifth cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "ester-[part of]-tail intervertebral disc-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "ester-[part of]-nucleus pulposus-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "ester-[part of]-intervertebral disk of third cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "ester-[part of]-intervertebral disk of thoracic vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "ester-[is input of]-chondroitin sulfate binding-[has input]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "sulfuric ester", "paths": ["sulfuric ester-[part of]-intervertebral disk of sacral vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfuric ester-[part of]-intervertebral disk of thoracic vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfuric ester-[part of]-nucleus pulposus-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfuric ester-[part of]-schreckstoff-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfuric ester-[is input of]-chondroitin sulfate catabolic process-[has input]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfuric ester-[is input of]-chondroitin sulfate binding-[has input]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfuric ester-[part of]-intervertebral disk of atlas-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfuric ester-[part of]-intervertebral disk of cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfuric ester-[part of]-tail intervertebral disc-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfuric ester-[part of]-intervertebral disk of sixth cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfuric ester-[part of]-intervertebral disk of lumbar vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfuric ester-[part of]-intervertebral disk of seventh cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfuric ester-[part of]-intervertebral disk of fifth cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfuric ester-[part of]-intervertebral disk of fourth cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfuric ester-[part of]-intervertebral disk of axis-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfuric ester-[is output of]-chondroitin sulfate biosynthetic process-[has output]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfuric ester-[part of]-intervertebral disk of third cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "sulfuric acid derivative", "paths": ["sulfuric acid derivative-[part of]-intervertebral disk of thoracic vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfuric acid derivative-[part of]-intervertebral disk of axis-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfuric acid derivative-[part of]-intervertebral disk of cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfuric acid derivative-[part of]-schreckstoff-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfuric acid derivative-[part of]-intervertebral disk of sacral vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfuric acid derivative-[is input of]-chondroitin sulfate binding-[has input]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfuric acid derivative-[is input of]-chondroitin sulfate catabolic process-[has input]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfuric acid derivative-[part of]-intervertebral disk of sixth cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfuric acid derivative-[part of]-intervertebral disk of seventh cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfuric acid derivative-[part of]-intervertebral disk of lumbar vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfuric acid derivative-[part of]-intervertebral disk of fifth cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfuric acid derivative-[is output of]-chondroitin sulfate biosynthetic process-[has output]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfuric acid derivative-[part of]-intervertebral disk of third cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfuric acid derivative-[part of]-intervertebral disk of atlas-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfuric acid derivative-[part of]-intervertebral disk of fourth cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfuric acid derivative-[part of]-nucleus pulposus-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfuric acid derivative-[part of]-tail intervertebral disc-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "aminoglycan", "paths": ["aminoglycan-[part of]-intervertebral disk of third cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "aminoglycan-[part of]-tail intervertebral disc-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "aminoglycan-[part of]-intervertebral disk of thoracic vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "aminoglycan-[part of]-intervertebral disk of cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "aminoglycan-[part of]-schreckstoff-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "aminoglycan-[part of]-intervertebral disk of fifth cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "aminoglycan-[part of]-intervertebral disk of sixth cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "aminoglycan-[part of]-intervertebral disk of axis-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "aminoglycan-[part of]-nucleus pulposus-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "aminoglycan-[part of]-intervertebral disk of seventh cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "aminoglycan-[is input of]-chondroitin sulfate binding-[has input]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "aminoglycan-[part of]-intervertebral disk of lumbar vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "aminoglycan-[part of]-intervertebral disk of atlas-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "aminoglycan-[part of]-intervertebral disk of sacral vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "aminoglycan-[is output of]-chondroitin sulfate biosynthetic process-[has output]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "aminoglycan-[part of]-intervertebral disk of fourth cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "aminoglycan-[is input of]-chondroitin sulfate catabolic process-[has input]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "polysaccharide derivative", "paths": ["polysaccharide derivative-[part of]-intervertebral disk of third cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "polysaccharide derivative-[part of]-intervertebral disk of lumbar vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "polysaccharide derivative-[part of]-schreckstoff-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "polysaccharide derivative-[part of]-intervertebral disk of thoracic vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "polysaccharide derivative-[part of]-nucleus pulposus-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "polysaccharide derivative-[is input of]-chondroitin sulfate catabolic process-[has input]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "polysaccharide derivative-[part of]-tail intervertebral disc-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "polysaccharide derivative-[part of]-intervertebral disk of axis-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "polysaccharide derivative-[part of]-intervertebral disk of cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "polysaccharide derivative-[part of]-intervertebral disk of fifth cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "polysaccharide derivative-[is input of]-chondroitin sulfate binding-[has input]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "polysaccharide derivative-[is output of]-chondroitin sulfate biosynthetic process-[has output]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "polysaccharide derivative-[part of]-intervertebral disk of atlas-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "polysaccharide derivative-[part of]-intervertebral disk of sixth cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "polysaccharide derivative-[part of]-intervertebral disk of fourth cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "polysaccharide derivative-[part of]-intervertebral disk of sacral vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "polysaccharide derivative-[part of]-intervertebral disk of seventh cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "sulfur oxoacid derivative", "paths": ["sulfur oxoacid derivative-[part of]-tail intervertebral disc-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfur oxoacid derivative-[part of]-intervertebral disk of fourth cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfur oxoacid derivative-[part of]-intervertebral disk of seventh cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfur oxoacid derivative-[part of]-intervertebral disk of sacral vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfur oxoacid derivative-[part of]-nucleus pulposus-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfur oxoacid derivative-[part of]-intervertebral disk of axis-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfur oxoacid derivative-[part of]-intervertebral disk of sixth cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfur oxoacid derivative-[part of]-intervertebral disk of fifth cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfur oxoacid derivative-[is input of]-chondroitin sulfate binding-[has input]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfur oxoacid derivative-[is output of]-chondroitin sulfate biosynthetic process-[has output]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfur oxoacid derivative-[part of]-intervertebral disk of lumbar vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfur oxoacid derivative-[part of]-intervertebral disk of cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfur oxoacid derivative-[is input of]-chondroitin sulfate catabolic process-[has input]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfur oxoacid derivative-[part of]-schreckstoff-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfur oxoacid derivative-[part of]-intervertebral disk of atlas-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfur oxoacid derivative-[part of]-intervertebral disk of thoracic vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "sulfur oxoacid derivative-[part of]-intervertebral disk of third cervical vertebra-[has part]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type"]}, {"name": "(S)-lipoic acid", "paths": ["(S)-lipoic acid-[has part]-SULFUR, PRECIPITATED-[part of]-METHANESULFONYLMETHANE-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "(S)-lipoic acid-[has part]-SULFUR, PRECIPITATED-[part of]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "(S)-lipoic acid-[has part]-water-[part of]-chondroitin sulfate-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "(S)-lipoic acid-[has part]-water-[part of]-silicon dioxide-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "(S)-lipoic acid-[has part]-hydrogen(.)-[part of]-silicon dioxide-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "(S)-lipoic acid-[has part]-water-[part of]-propranolol-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type", "(S)-lipoic acid-[has part]-hydrogen(.)-[part of]-propranolol-[treats or applied or studied to treat]-Ehlers-Danlos syndrome, hypermobility type"]}]}
